Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Scott D. Jewell Image

      Scott D. Jewell, PhD

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. Scott D. Jewell

      Dr. Jewell joined MD Anderson in 2024 as Deputy Division Head and Professor of Pathology, in the Division of Pathology and Laboratory Medicine, and the Department of Anatomic Pathology. Dr. Jewell has assumed responsibilities for Tissue Utilization and Biorepositories. Dr. Jewell came from the Van Andel Institute (VAI) and previously from The Ohio State University, where he was Director of Core Technologies and the Human Tissue Research Network (HTRN), respectively.


      Dr. Jewell received his B.S. in microbiology, and M.S. and PhD in Experimental Pathology and Immunology from The Ohio State University. He has worked in the field of clinical and anatomic pathology, biospecimen science and biobanking for more than 40 years. Key projects in biobanking include the Midwest Division of the NCI Cooperative Human Tissue Network, the NCI National Clinical Trials Network (NCTN) Alliance for Clinical Trials and Oncology (formerly the Cancer and Leukemia Group B (CALGB) Pathology Coordinating Office, and OSU’s Comprehensive Cancer Center’s Tissue Procurement Shared Resource (TPSR) and Biorepository and Biospecimen Resource (BBR). Dr. Jewell served as principal investigator for several NIH initiatives; including the Biospecimen Core Resource (BCR) for the NCI Moonshot Biobank, NCI Clinical Proteomics Tumor Analysis Consortium (CPTAC), the Comprehensive Biospecimen Resource (CBR) for the NHGRI/NCI Genotype Tissue Expression (GTEx) project, and the NCI’s Biorepository and Biospecimen Research Branch (BBRB) Biospecimen Preanalytical Variable (BPV) study and as a biobank for several research foundations. As a biorepository resource, these projects focused on biospecimen collection, preservation, processing, histology services, histopathology evaluation, analyte derivation, quality assessment, biobanking and distribution of biospecimens for research.


      Dr. Jewell has served on several national and international committees, journal editorial boards, scientific external advisory boards, and as a reviewer of grants and contracts for NIH. He was elected President of the International Society for Biological and Environmental Repositories (ISBER) in 2011 and the Great Lakes Biorepository Research Network (GLBRN). Dr. Jewell was also Chair and member of the NCI Clinical Cooperative Group Banking Committee, and the Biospecimen Subcommittee for NCI, AACR, and FDA’s Critical Path Initiative. Dr. Jewell served as an appointed member of the original College of American Pathologists (CAP) Biorepository Accreditation Program (BAP) committee from 2012-2018. The Pathology and Biorepository Core (PBC) at VAI was one of the first accredited biorepositories receiving accreditation in 2012. Dr. Jewell has also served as the IRB Chair at VAI and on the Board for the Michigan Neonatal Biobank; a component of the State of Michigan’s Department of Health and Human Services (MDHHS) Neonatal Biotrust.


      Dr. Jewell’s research has focused primarily on biospecimen science to improve the standards and practices for the collection, processing, storage, and distribution of biospecimens. As a graduate school mentor, he supervised doctoral research in hypermutation and neoantigens in primary and recurrent medulloblastoma.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Deputy Division Head, Anatomic Pathology - Research, Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Deputy Division Head, Professor, Anatomic Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas

      Professor Emeritus, Van Andel Institute, Grand Rapids, Michigan

      Education & Training

      Degree-Granting Education

      1993Ohio State University, Columbus, Ohio, US, Experimental Pathology and Immunology, PhD
      1980Ohio State University, Columbus, Ohio, US, Experimental Pathology, MS
      1974Ohio State University, Columbus, Ohio, US, Microbiology, BS

      Experience & Service

      Faculty Academic Appointments

      Professor, Van Andel Institute Graduate School, Grand Rapids, Michigan, 2010 - 2013

      Associate Professor, Pathology, Ohio State University, Columbus, Ohio, 2007 - 2010

      Clinical Associate Professor, Pathology, Ohio State University, Columbus, Ohio, 2001 - 2007

      Clinical Assistant Professor, Pathology, Ohio State University, Columbus, Ohio, 1998 - 2001

      Assistant Professor, Pathology, Ohio State University, Columbus, Ohio, 1994 - 1998

      Adjunct Assistant Professor, Pathology, Ohio State University, Columbus, Ohio, 1994 - 1994

      Administrative Appointments/Responsibilities

      Advisory Board Member, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, 2020

      Executive Committee Member, Great Lakes Biorepository Research Network, 2017 - Present

      External Advisory Board Member, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, 2017

      Past President, Great Lakes Biorepository Research Network, 2015 - 2016

      President, Great Lakes Biorepository Research Network, 2014 - 2015

      Advisory Board Member, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, 2014

      Executive Operations Board Member, Western Michigan Cancer Research Consortium, National Institute of Health, National Cancer Institute, Grand Rapids, Michigan, 2013 - 2023

      Director, Van Andel Institute, Grand Rapids, Michigan, 2013 - 2023

      Director, Van Andel Institute, Grand Rapids, Michigan, 2013 - 2023

      Founding Member, Great Lakes Biorepository Research Network, 2012 - 2023

      Board Member, Michigan Neonatal BioTrust, Wayne State University, Detriot, Michigan, 2012 - 2023

      Principle Investigator, Genotype Tissue Expression (GTEx) Consortium, National Institute of Health, National Human Genome Research Institute, 2011 - 2021

      Past President, International Society of Biological and Environmental Repositories, 2011 - 2012

      Director, Van Andel Institute, Grand Rapids, Michigan, 2010 - 2013

      Director, Program for Biospecimen Science, Van Andel Institute, Grand Rapids, Michigan, 2010 - 2013

      Senior Scientific Investigator, Van Andel Institute, Grand Rapids, Michigan, 2010 - 2010

      External Advisory Board, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, 2010 - Present

      Deputy Director, Van Andel Institute, Grand Rapids, Michigan, 2010 - 2012

      President, International Society of Biological and Environmental Repositories, 2010 - 2011

      President Elect, International Society of Biological and Environmental Repositories, 2009 - 2010

      Advisory Board Member, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, 2009

      Associate Director, Pathology, Ohio State University, Columbus, Ohio, 2008 - 2010

      Advisory Board Member, Infrastructure Program Technology, BioLibrary, Vancouver, British Columbia, 2006

      Advisory Board Member, Immunology Research, Michael Smith Foundation for Health Research, 2003

      Advisory Board Member, Commonwealth of Virginia Immunology Innovation, University of Virginia Center for Innovation, Charlottesville, Virginia, 2001

      Director of Operations, Pathology, Ohio State University, Columbus, Ohio, 1999 - 2001

      Scientific Director, Pathology, Ohio State University, Columbus, Ohio, 1999 - 2010

      Coordinator, Pathology, Ohio State University, Columbus, Ohio, 1999 - 2010

      Director, Pathology, Ohio State University, Columbus, Ohio, 1999 - 2010

      Executive Director, Pathology Research Core Labs and Biorepositories, Ohio State University, Columbus, Ohio, 1998 - 2010

      Operations Officer, Pathology, Ohio State University, Columbus, Ohio, 1998 - 2001

      Director, Pathology, Ohio State University, Columbus, Ohio, 1997 - 2002

      Director, Pathology, Ohio State University, Columbus, Ohio, 1993 - 1997

      Director, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, 1993 - 2010

      Other Professional Positions

      Research Scientist, Ohio State University, Columbus, Ohio, 1998 - 2010

      Clinical Instructor, Ohio State University, Columbus, Ohio, 1993 - 1994

      Program Coordinator, Cooperative Human Tissue Network, Ohio State University, Columbus, Ohio, 1990 - 1993

      Graduate Research Associate, Ohio State Univeristy, Columbus, Ohio, 1989 - 1990

      Research Associate II, Ohio State University, Columbus, Ohio, 1985 - 1989

      Immunohistochemistry Specialist, American Dade, Miami, Florida, 1984 - 1985

      Area-Technical-Director, Immunochemistry, Chemistry, Hematology, Instrumentation Laboratories, Inc, Lexington, Massachusetts, 1981 - 1984

      Medical and Senior Medical Technologist (ASCP)(SI), Ohio State University, Columbus, Ohio, 1974 - 1981

      Intramural Institutional Committee Activities

      Member, Curriculum Implementation Task Force, Van Andel Research Institute Graduate School, 2020 - 2021

      Chair, Comprehensive Exam Organizing Committee, Van Andel Research Institute Graduate School, 2017 - 2020

      Chair, Institutional Review Board, Van Andel Institute, 2014 - 2023

      Member, Conflict of Interest Committee, Van Andel Institute, 2014 - 2016

      Chair, Core User Committee, Van Andel Institute, 2013 - 2015

      Member, Reappointment and Promotion Board Review, Van Andel Institute, 2013 - 2014

      Vice Chair, Institutional Review Board, Van Andel Institute, 2013 - 2014

      Member, Institutional Review Board, Van Andel Institute, 2012 - 2014

      Member, Graduate Program Committee, Van Andel Research Institute Graduate School, 2011 - 2017

      Member, Counsel Research Affairs, Van Andel Institute, 2011 - 2013

      Member, Inter-Institutional Executive, Van Andel Institute, 2011 - 2012

      Member, Clinical Scientific Review Committee, Ohio State University, 2008 - 2010

      Member, Executive Committee, Ohio State University, 2008 - 2010

      Member, Research Information System Steering Team, Ohio State University, 2007 - 2010

      Member, Consent and Biorepository Taskforce, Ohio State University, 2007 - 2008

      Member, Biomedical Research Tower, Histology Lab Core Design, Ohio State University, 2003 - 2006

      Member, Tissue Banking Steering Committee, Ohio State University, 2003 - 2006

      Member, Pathology Bioinformatics Committee, Ohio State University, 2001 - 2008

      Member, Tissue Archive Committee, Ohio State University, 2000 - 2008

      Director, Tissue Procurement Services, Ohio State University, 1999 - 2010

      Member, Quality Management Committee, Ohio State University, 1999 - 2008

      Officer, Operations Committee, Ohio State University, 1998 - 2001

      Chair, Subcommittee for Student Funding, Ohio State University, 1997 - 2001

      Director, Undergraduate Student Summer Internship Program Committee, Ohio State University, 1997 - 2001

      Member, Pathology Research Committee, Ohio State University, 1996 - 2006

      Member, Case Studies Committee, Ohio State University, 1996 - 1998

      Member, Committee on Evaluations, Ohio State University, 1996

      Member, Pathology Graduate Studies Committee, Ohio State University, 1995 - 2001

      Member, Promotion and Tenure Committee, Ohio State University, 1994 - 1996

      Member, Medical Center Information Systems, Ohio State University, 1994 - 1995

      Member, Computer Committee, Ohio State University, 1993 - 1996

      Director, Clinical Image Analysis Systems Committee, Ohio State University, 1993 - 1996

      Director, Tissue Procurement Shared Resource Committee, Ohio State University, 1992 - 2010

      Extramural Institutional Committee Activities

      Executive Committee Member, Biorepository Accreditation Committee, College of American Pathologist, 2014 - 2023

      Member, Executive Committee, Great Lakes Biorepository Research Network, 2014 - 2023

      Member, Management Transition Team, International Society for Biological and Environmental Repositories, 2012 - 2013

      Member, Biorepository Accreditation Program Advisory Committee, College of American Pathologists, 2011 - 2012

      Member, Working Group for Biorepository Accreditation, College of American Pathologist, 2011 - 2012

      Member, Publications Committee, International Society for Biological and Environmental Repositories, 2010 - 2023

      ISBER Representative, Committee, American Society of Investigative Pathology, 2010 - 2012

      Member, External Advisory Committee, University of Kentucky, 2009 - Present

      Member, Finance Committee, International Society for Biological and Environmental Repositories (ISBER), 2009 - 2021

      Member, Strategic Planning Committee, International Society for Biological and Environmental Repositories, 2009 - 2013

      Member, Executive Committee, International Society for Biological and Environmental Repositories, 2009 - 2012

      Chair, Informed Consent Working Group, International Society for Biological and Environmental Repositories, 2008 - 2013

      Co-Chair, Informed Consent for Biospecimens, International Society for Biological and Environmental Repositories, 2008 - 2013

      Member, Working Group for the Biospecimen Research Database, National Cancer Institute, 2008 - 2010

      Vice Chair, Pathology Committee, National Cancer Institute, University of Chicago, 2006 - 2010

      Co-Chair, Best Practices and Operations Subcommittee, National Cancer Institute, 2006 - 2010

      Chair, National Cancer Institute Group Banking Committee, National Cancer Institute, 2006 - 2008

      Chair, Biospecimen Research Special Interest Group, International Society for Biological and Environmental Repositories, 2006 - 2007

      Member, Program Committee, International Society for Biological and Environmental Repositories, 2004 - 2012

      Chair, Group Banking Committee, National Cancer Institute, 2004 - 2006

      Chair, Operations and Best Practices Subcommittee, National Cancer Institute, 2004 - 2006

      Chair, National Committee of Laboratory Standards, National Cancer Institute, 2003 - 2006

      Chair, GP30 Tissue Procurement of Human Specimens Sub-Committee, National Cancer Institute, 2003 - 2006

      Chair, LabTrak Implementation Committee, National Cancer Institute, University of Chicago, 2002 - 2004

      Member, Solid Tumor Correlative Science Committee, National Cancer Institute, University of Chicago, 2001 - 2010

      Member, Group Banking Committee, National Cancer Institute, 2000 - 2010

      Member, Intergroup Specimen Banking Committee, National Cancer Institute, 2000 - 2001

      Member, Pathology Committee, National Cancer Institute, University of Chicago, 1999 - 2010

      Member, Coordinating Committee, National Cancer Institute, 1999 - 2010

      Member, Strategic Planning Committee, National Cancer Institute, 1998 - 2010

      Member, Regulatory Affairs Committee, National Cancer Institute, 1995 - 2010

      Member, Quality Control Sub-Committee, National Cancer Institute, 1994 - 2010

      Member, Informatics Sub-Committee, National Cancer Institute, 1993 - 2010

      Chair, Informatics Sub-Committee, National Cancer Institute, 1993 - 1996

      Chair, Computer Sub-Committee, National Cancer Institute, 1990 - 1997

      Member, Coordinating Committee, National Cancer Institute, 1990 - 1996

      Editorial Activities

      Reviewer, Journal of Molecular Diagnostics, 2015

      Reviewer, Nature Biotechnology, 2014

      Reviewer, American Association for Cancer Research, Clinical Cancer Research, 2012

      Reviewer, BioMed Central, 2012

      Editorial Board Member, Biopreservation and Biobanking, 2011 - Present

      Reviewer, Science, 2008 - 2016

      Reviewer, PLOS One, 2007 - 2010

      Reviewer, Cancer Epidemiology, Biomarkers & Prevention, 2006 - 2010

      Reviewer, American Journal of Clinical Pathology, 2000 - 2005

      Reviewer, American Journal of Pathology, 2000 - 2004

      Reviewer, Journal of Immunology, 1998 - 2003

      Reviewer, Journal of Histotechnology, 1996 - 2010

      Honors & Awards

      2012 - 2013Outstanding Service Award, International Society of Biological and Environmental Repositories
      2004Award Recipient, Breast Cancer Research Foundation, New York, New York
      2003Best of 2002 Manuscript Articles, American Journal of Pathology
      2002Award Recipient, Breast Cancer Research Foundation, New York, New York
      1993Graduate Student of the Year, Department of Pathology, Ohio State University, Columbus, Ohio

      Professional Memberships

      Public Responsibility in Medicine and Research

      2013 - 2018

      College of American Pathologist

      2010 - 2018

      American Association for Cancer Research

      2005 - 2014

      American Society for Investigative Pathology

      2002 - 2010

      International Society for Biological and Environmental Repositories

      2000 - 2023

      Histochemistry Society

      2000 - 2012

      Cancer and Leukemia Group B

      1997 - 2010

      AIDS and Cancer Specimen Resource

      1995 - 2013

      Ohio Academy of Science

      1993 - 2010

      Clinical Laboratory Standards Institute

      1993 - 2000

      American Association for the Advancement of Science

      1992 - Present

      Cooperative Human Tissue Network

      1990 - 2010

      Selected Presentations & Talks

      Local Presentations

      1. 2014. Incidental Findings and Return of Results from Biorepository Specimens. Invited. Michigan Research Ethics Conference. Grand Rapids, Michigan, US.
      2. 2012. Human Biorepositories and Ethics. Invited. Michigan Research Ethics Consortium. Grand Rapids, Michigan, US.
      3. 2011. Regulatory Compliance in Biobanking. Invited. Grand Rapids, Michigan, US.
      4. 2011. Ethical Considerations in Biobanking. Invited. Internal Medicine Grand Rounds. Grand Rapids, Michigan, US.
      5. 2011. Tissue is the Issue. Invited. Help on the Hill. Grand Rapids, Michigan, US.
      6. 2008. Tissue Banking. Invited. Biomedical Informatics. Columbus, Ohio, US.
      7. 2007. Presentation on the procurement of human tissues for research. Invited. Columbus, Ohio, US.
      8. 2006. CALGB-PCO and the Human Tissue Resource Network. Invited. NCI Group Banking Committee Face-to-Face Meeting. Columbus, Ohio, US.
      9. 2005. Workshop on the collection, processing and banking of human specimens. Invited. Columbus, Ohio, US.
      10. 2005. Pathology Grand Rounds. Invited. Columbus, Ohio, US.
      11. 1999. Current Issues in Infectious Disease. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      12. 1998. Liver associated mechanisms of oral tolerance. Invited. Immunology Seminar Program. Columbus, Ohio, US.
      13. 1998. Transplantation. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      14. 1998. Student Research Update. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      15. 1998. Cancer Immunology and Grant Writing. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      16. 1998. Prions. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      17. 1997. History of Tissue Procurement Services. Invited. Seminars in Pathology. Columbus, Ohio, US.
      18. 1997. Student Research Update. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      19. 1997. AIDS. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      20. 1997. Gastroenterology Pathology. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      21. 1996. Flow Cytometry and Image Analysis. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      22. 1996. Renal Pathology. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      23. 1996. Autoimmune Disease Animal Models. Invited. Seminar in Molecular Mechanism of Disease. Columbus, Ohio, US.
      24. 1995. Localization of murine CC49 in the lymph nodes of colorectal patients. Invited. Columbus, Ohio, US.
      25. 1995. Immunobiology of colon cancer associated with the injection of a mouse anti TAA monoclonal antibody. Invited. Seminars in Medical Microbiology and Immunology. Columbus, Ohio, US.

      Regional Presentations

      1. 2017. Update on the State of Michigan’s Neonatal Biobank. Invited. 2017 Annual Great Lakes Breast Cancer Research Scientific Symposium, Michigan, US.
      2. 2016. Enabling Scientific Progress while Protecting Privacy. Invited. BioTrust Joint Board Meeting. Lansing, Michigan, US.
      3. 2015. Process and Science of Biobank Research, Specific Research Policies. Invited. Ethical Issues in Biobank Research Deliberation Session. Ann Arbor, Michigan, US.
      4. 2013. The Ever-Changing Complexity of Biobanking. Invited. Great Lakes Biorepository Network. Royal Oak, Michigan, US.
      5. 2013. Building a Cancer Network. Invited. Mercy Cancer Network. Lansing, Michigan, US.
      6. 2012. Advancing BioBanking in The Great Lakes Area. Invited. 5th Annual BioBank and Erb Family Core Molecular Laboratories Symposium. Rochester, Michigan, US.
      7. 2011. Organization of a Biospecimen Resource for Personalized Healthcare. Invited. Karmanos Cancer Institute Grand Rounds. Detroit, Michigan, US.
      8. 2011. Biobanking to the Rescue. Invited. Bladder Cancer Think Tank 2010. Traverse City, Michigan, US.
      9. 2007. Biospecimen banking for personalized care. Invited. Personalized and Predictive Medicine Seminar. Cincinnati, Ohio, US.
      10. 1994. Basic Immunobiology. Invited. RIGS technology training program. Dublin, Ohio, US.

      National Presentations

      1. 2018. Biospecimen Core Resources for Consortium Projects in Cancer Research. Invited. Expert Session. Chicago, Illinois, US.
      2. 2015. Assessment of the Biological Quality of Biospecimens. Invited. Bethesda, Maryland, US.
      3. 2014. Experimental Modeling of RNA Degradation in Tissue Samples: Multi-Modality Measures and Biological Pathway Correlates. Invited. Annual Meeting. Orlando, Florida, US.
      4. 2013. Biospecimen and Tissue Procurement, Flow Cytometry, Cancer Research Informatics, Biostatistics Shared Resource Facilities. Invited. Lexington, Kentucky, US.
      5. 2012. Regulatory Considerations for Biorepositories: Navigating HHS, FDA, HIPAA and Informed Consent. Invited. Huron Life Sciences, Clinical Research Management and Webinar Series. Columbus, Ohio, US.
      6. 2011. The Program for Biospecimen Science. Invited. Annual Scientific Retreat. Phoenix, Arizona, US.
      7. 2011. Regulatory and Management Considerations for Biorepositories. Invited. Clinical Research Management and Webinar Series. Columbus, Ohio, US.
      8. 2009. Tissue Fixation for Morphological Analysis & Molecular Profiling. Invited. Experimental Biology Conference and Histochemical Society Annual Meeting. New Orleans, Louisiana, US.
      9. 2008. Measurements of Degradation in Frozen Tissue: Effects of Packaging, Temperature, and Length of Storage. Invited. Bethesda, Maryland, US.
      10. 2008. Sample Storage and Adverse Events. Invited. Biospecimen Research Network Symposium. Washington, District of Columbia, US.
      11. 2006. Biospecimen Research. Invited. Special Interest Group Seminars. Bethesda, Maryland, US.
      12. 2003. Human tissues for drug discovery through preclinical research. Invited. Boston, Massachusetts, US.
      13. 1993. Oral tolerance in experimental autoimmune encephalomyelitis (EAE): Reversal of T cell anergy. Invited. Federation of American Societies for Experimental Biology. Denver, Colorado, US.

      International Presentations

      1. 2012. Comprehensive Biospecimen Resource for the caHUB and the National Institutes of Health’s Common Fund Genotype Tissue-Expression (GTex) Program. Invited. Vancouver, CA.
      2. 2007. Case Study: An Examination of the Downstream Consequences of an Excursion or Adverse Event During Sample Storage. Invited. Munich, US.
      3. 1996. Effects on lymphocyte proliferation by human mucin isolated from colon cancer and normal colonic mucosa. Invited. Kathmandu, US.
      4. 1996. Radioimmunoguided detection of colon cancer: A survival update. Invited. Kathmandu, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - Present
      Title:ECOG-ACRIN Biospecimen Bank to Support NCTN
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:U24CA196172
      Date: 2024 - Present
      Title:Cancer Center Support (CORE) Grant
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      ID:P30CA016672-48
      Date: 2020 - 2024
      Title:CPTAC BCR
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:20X044F
      Date: 2020 - 2023
      Title:Cancer Moonshot BCR
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:20X062Q
      Date: 2016 - 2023
      Title:Tuberous Sclerosis Breeding Facility
      Funding Source:Tuberous Sclerosis Alliance TS8
      Role:PI
      Date: 2015 - 2020
      Title:Clinical Proteomic Technology Assessment for Cancer Program (CPTAC)
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:HHSN210500055C
      Date: 2015 - 2016
      Title:Genotype Tissue Expression Project (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2014 - 2015
      Title:Genotype Tissue Expression Project (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2014 - 2023
      Title:Tuberous Sclerosis Alliance TSC Biosample Repository
      Funding Source:Tuberous Sclerosis Alliance
      Role:PI
      ID:2014-BSR-01-A3
      Date: 2014 - 2019
      Title:Multiple Myeloma Research Foundation Sub award via Translational Genomics Research Institute (TGen)
      Funding Source:MMRF Janssen Biospecimen Kits
      Role:PI
      Date: 2013 - 2015
      Title:Public Preferences for Addressing Donors’ Moral Concerns about Biobank Research
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      Date: 2013 - 2015
      Title:Hermelin Brain Tumor Genomics Based Medicine (hGBM) project
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      Date: 2013 - 2014
      Title:Genotype Tissue Expression Project (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2012 - 2013
      Title:Research Studies in Cancer and Normal Tissue Acquisition and Processing Variables (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2012 - 2013
      Title:Genotype Tissue Expression Project (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2012 - 2013
      Title:Genotype Tissue Expression Project (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2011 - 2012
      Title:caHUB Comprehensive Biospecimen Resource Master Agreement and Genotype- Tissue Expression (GTEx) Task Order
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2011 - 2013
      Title:caHUB Comprehensive Biospecimen Resource Master Agreement and Genotype- Tissue Expression
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human ServicesNational Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2011 - 2023
      Title:Biobank & Lab Support: Prospective, Observational, Longitudinal Study
      Funding Source:Translational Genomics Research Institute
      Role:PI
      Date: 2011 - 2011
      Title:caHUB Comprehensive Biospecimen Resource Master Agreement and Genotype- Tissue Expression
      Funding Source:National Institute of Health, National Cancer Institute, United States Department of Health and Human Services
      Role:PI
      ID:10XS1035
      Date: 2011 - 2023
      Title:caHUB – Biospecimen Source Site (BSS)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:10ST1105/11XS1006
      Date: 2010 - 2016
      Title:caHUB – Comprehensive Biorepository Resource (CBR)
      Funding Source:National Institute of Health, National Cancer Institute, SAIC-Frederick
      Role:PI
      ID:10ST1035/10XS-1035
      Date: 2009 - 2013
      Title:Racial/ethnic disparities in breast cancer care, survivorship, and work outcomes
      Funding Source:National Institute of Health, University of Michigan
      Role:Co-PI
      Date: 2009 - 2011
      Title:Eastern Cooperative Oncology Group (ECOG)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      Date: 2009 - 2015
      Title:Cancer & Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, University of Chicago
      Role:PI
      Date: 2009 - 2015
      Title:CALGB Molecular Reference Lab
      Funding Source:National Institute of Health, National Cancer Institute, University of Chicago
      Role:PI
      Date: 2009 - 2011
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:10603
      Date: 2009 - 2014
      Title:IBCSG 25-02 Tamoxifen and Exemestane Trial (TEXT)
      Funding Source:International Breast Cancer Study Group (IBCSG)
      Role:PI
      Date: 2008 - 2012
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:40502
      Date: 2008 - 2013
      Title:Mid-Region AIDS and Cancer Specimen Resource (ACSR)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-PI
      Date: 2008 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, Millennium Pharmaceuticals
      Role:PI
      ID:50403
      Date: 2008 - 2011
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:40503
      Date: 2008 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, Roswell Park Cancer Institute
      Role:PI
      ID:90206
      Date: 2008 - 2009
      Title:Genetic and signaling pathways in epithelial thyroid cancer
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 2008 - 2013
      Title:Cooperative Human Tissue Network (CHTN)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      Date: 2008 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation
      Role:PI
      ID:50103
      Date: 2008 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:40601/40603
      Date: 2007 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Biogen Idec
      Role:PI
      ID:50201
      Date: 2007 - 2008
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, Ortho Biotech
      Role:PI
      ID:50502
      Date: 2007 - 2008
      Title:Cancer and Leukemia Group B PCO Molecular Reference Laboratory
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, University of Chicago
      Role:PI
      Date: 2007 - 2008
      Title:Clinical Trials Evaluation Program (CTEP): RIMS integration project
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, University of Chicago
      Role:PI
      Date: 2007 - 2012
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:90203
      Date: 2007 - 2012
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation
      Role:PI
      Date: 2007 - 2008
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, University of Chicago
      Role:PI
      ID:20501
      Date: 2007 - 2008
      Title:Pathology Coordinating Office (PCO), HSR supplemental funds, GBC
      Funding Source:National Institute of Health, National Cancer Institute, University of Chicago
      Role:PI
      Date: 2006 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Genentech
      Role:PI
      ID:90401
      Date: 2006 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Breast Cancer Research Foundation
      Role:PI
      ID:9342
      Date: 2006 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Breast Cancer Research Foundation
      Role:PI
      ID:9344
      Date: 2006 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:7342
      Date: 2006 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation
      Role:PI
      Date: 2006 - 2007
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, ImClone
      Role:PI
      ID:80203
      Date: 2006 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Bristol, Meyer, Squibb
      Role:PI
      ID:30407
      Date: 2005 - 2009
      Title:Tissue Procurement Shared Resource, Comprehensive Cancer Center
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 2005 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Novartis
      Role:PI
      ID:90202
      Date: 2005 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, Genentech
      Role:PI
      ID:90206
      Date: 2005 - 2008
      Title:Core C: Reducing cervical cancer in Appalachia
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 2005 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, Bristol, Meyer, Squibb
      Role:PI
      ID:80405
      Date: 2005 - 2010
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute Group Banking Committee, CALGB Foundation, University of Chicago
      Role:PI
      Date: 2005 - 2006
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, PCO Banking
      Role:PI
      ID:30107
      Date: 2005 - 2009
      Title:Stress, the immune system and non-melanoma skin cancer (BCC)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 2004 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation
      Role:PI
      ID:80303
      Date: 2004 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute
      Role:PI
      ID:80303
      Date: 2004 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:CALGB Foundation, Breast Cancer Research Foundation
      Role:PI
      Date: 2004 - 2009
      Title:NCIC CTG MA-27
      Funding Source:CALGB Foundation, Pfizer
      Role:PI
      Date: 2004 - 2005
      Title:The Ohio BioRepository
      Funding Source:Omeris
      Role:PI
      Date: 2003 - 2010
      Title:North American Breast Cancer Repository Bank for International Breast Cancer Study Group (IBCSG)
      Funding Source:Pharmacia, Pfizer
      Role:PI
      Date: 2003 - 2009
      Title:Cancer and Leukemia Group B
      Funding Source:National Institute of Health, National Cancer Institute, CALGB Foundation, University of Chicago
      Role:PI
      Date: 2002 - 2005
      Title:Predicting the adverse consequences of estrogen deprivation of lipid metabolism by analysis of estrogen reception polymorphisms
      Funding Source:Breast Cancer Research Foundation, CALGB Foundation
      Role:PI
      Date: 2001 - 2007
      Title:Tumor markers to predict treatment response
      Funding Source:University of North Carolina
      Role:PI
      Date: 2001 - 2008
      Title:Cooperative Human Tissue Network (CHTN)
      Funding Source:National Insitute of Health, National Cancer Institute
      Role:Co-I
      Date: 2000 - 2003
      Title:Prostate cancer tissue resource
      Funding Source:Cancer Research Institute
      Role:PI
      Date: 2000 - 2003
      Title:ErbB2/p53 and taxane chemotherapy for breast cancer
      Funding Source:Dana Farber
      Role:PI
      Date: 1999 - 2004
      Title:Adenoma polyp tissue bank for the prevention of sporadic colorectal adenomas with celecoxib
      Funding Source:National Institute of Health, National Cancer Institute, Strang Research Center
      Role:PI
      Date: 1998 - 2002
      Title:AIDS malignancy bank
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 1997 - 1998
      Title:The role of the liver on the induction of oral tolerance
      Funding Source:Ohio State University
      Role:PI
      Date: 1996 - 1999
      Title:Phase II b chemoprevention trial of difluoromethylornithine (DMFO) in human subjects with dysplastic and intestinal-type Barrett's Esophagus
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I
      Date: 1995 - 1996
      Title:Immunobiology of lymph nodes in colorectal cancer
      Funding Source:American Cancer Society, Ohio State University Comprehensive Cancer Center
      Role:PI
      Date: 1994 - 1997
      Title:The Characterization of lymphocytes from near and regional lymph nodes draining the site of colorectal carcinoma: A flow cytometric evaluation of the immunobiology of RIGS positive and negative lymph nodes
      Funding Source:Neoprobe Corporation
      Role:PI
      Date: 1994 - 1995
      Title:Effects of oral administration of alpha-interferon on the induction of experimental autoimmune encephalomyelitis (EAE): A dosage and feeding frequency analysis
      Funding Source:Amarillo Cell Culture
      Role:PI
      Date: 1994 - 1995
      Title:Effects of low dose oral administration of alpha-interferon on the induction of experimental autoimmune encephalomyelitis
      Funding Source:Amarillo Cell Culture
      Role:PI
      Date: 1990 - 2010
      Title:Cooperative Human Tissue Network (CHTN)
      Funding Source:National Institute of Health, National Cancer Institute
      Role:Co-I

      Selected Publications

      Peer-Reviewed Articles

      1. Damico H, C Sheridan RT, Blanski AA, Escobar Galvis ML, Evans T, Williams BO, Jewell SD, Rohrer DC. Comparative Analysis of the Ficoll-Paque and Miltenyi autoMACS® PBMC Isolation Methods. Biopreserv Biobank, 2026. e-Pub 2026.
      2. Kołodziejczak-Guglas, I, Simões, RL, de Souza Santos, E, Demicco, EG, Lazcano Segura, RN, Ma, W, Wang, P, Geffen, Y, Storrs, E, Petralia, F, Colaprico, A, da Veiga Leprevost, F, Pugliese, P, Ceccarelli, M, Noushmehr, H, Nesvizhskii, AI, Kaminska, B, Priebe, W, Lubinski, J, Zhang, B, Lazar, A, Kurzawa, P, Mesri, M, Robles, AI, Francis, A, Paulovich, A, Calinawan, A, Iavarone, A, Chinnaiyan, AM, Wen, B, Reva, B, Druker, BJ, Lindgren, CM, Kumar-Sinha, C, Newton, CJ, Huang, C, Birger, C, Day, C, Mani, DR, Zhou, DC, Chan, D, Fenyö, D, Heiman, DI, Rykunov, D, Huntsman, E, Schadt, EE, Jaehnig, EJ, An, E, Rodrigues, FM, Jewell, SD. Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Cell Genom 5(6), 2025. e-Pub 2025. PMID: 40250426.
      3. Martins Rodrigues, F, Terekhanova, NV, Imbach, KJ, Clauser, KR, Esai Selvan, M, Mendizabal, I, Geffen, Y, Akiyama, Y, Maynard, M, Yaron, TM, Li, Y, Cao, S, Storrs, E, Gonda, OS, Gaite-Reguero, A, Govindan, A, Kawaler, E, Wyczalkowski, MA, Klein, R, Turhan, B, Krug, K, Mani, DR, Leprevost, FV, Nesvizhskii, AI, Carr, SA, Fenyö, D, Gillette, MA, Colaprico, A, Iavarone, A, Robles, AI, Huang, KL, Kumar-Sinha, C, Aguet, F, Lazar, A, Cantley, LC, Marigorta, UM, Gümüş, ZH, Bailey, M, Getz, G, Porta-Pardo, E, Ding, L, An, E, Anurag, M, Bavarva, J, Birger, C, Birrer, MJ, Calinawan, A, Ceccarelli, M, Jaehnig, EJ, Jewell, SD. Precision proteogenomics reveals pan-cancer impact of germline variants. Cell 188(9):2312-2335.e26, 2025. e-Pub 2025. PMID: 40233739.
      4. Savage, SR, Wang, Y, Chen, L, Jewell, SD, Newton, CJ, Dou, Y, Li, QK, Bathe, OF, Robles, AI, Omenn, GS, Thiagarajan, M, Zhang, H, Hostetter, G, Zhang, B. Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma. Clin Proteomics 21(1):7, 2024. e-Pub 2024. PMID: 38291365.
      5. Skerget, S, Penaherrera, D, Chari, A, Jagannath, S, Siegel, D, Vij, R, Orloff, GJ, Jakubowiak, AJ, Niesvizky, R, Liles, DK, Berdeja, JG, Levy, MY, Wolf, J, Usmani, S, Steis, RG, Srinivas, S, Roy, V, Rodríguez, P, Oriol, A, Kumar, SK, Krsnik, I, Matkiwsky, M, Girnius, SK, Conde, M, Chandra, S, Anderson, R, Solomon, W, Richards, DA, Patel, D, Menter, AR, Kaya, H, Hsu, G, Hassoun, H, Bargay, J, Anderson, L, Abella, E, Yalamachili, M, Wachsman, W, Volterra, F, Onitilo, AA, Min, F, Shieh, M, Bar, MH, Ngaiza, J, Harris, W, Sebag, M, Robles, R, Yost, KJ, Grossbard, M, Jewell, SD. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet 56(9):1878-1889, 2024. e-Pub 2024. PMID: 39160255.
      6. Li, GX, Chen, L, Hsiao, Y, Mannan, R, Zhang, Y, Luo, J, Petralia, F, Cho, H, Hosseini, N, da Veiga Leprevost, F, Calinawan, A, Li, Y, Anand, S, Dagar, A, Geffen, Y, Kumar-Sinha, C, Chugh, S, Le, A, Ponce, S, Guo, S, Zhang, C, Schnaubelt, M, Al Deen, NN, Chen, F, Caravan, W, Houston, A, Hopkins, AC, Newton, CJ, Wang, XM, Polasky, DA, Haynes, S, Yu, F, Jing, X, Chen, S, Robles, AI, Mesri, M, Thiagarajan, M, An, E, Getz, G, Linehan, WM, Hostetter, G, Jewell, SD, Chan, DW, Wang, P, Omenn, GS, Mehra, R, Ricketts, CJ, Ding, L, Chinnaiyan, AM, Lazar, A. Comprehensive proteogenomic characterization of rare kidney tumors. Cell Rep Med 5(5), 2024. e-Pub 2024. PMID: 38703764.
      7. Wu, Y, Terekhanova, NV, Caravan, W, Naser Al Deen, N, Lal, P, Chen, S, Mo, CK, Cao, S, Li, Y, Karpova, A, Liu, R, Zhao, Y, Shinkle, A, Strunilin, I, Weimholt, C, Sato, K, Yao, L, Serasanambati, M, Yang, X, Wyczalkowski, MA, Zhu, H, Zhou, DC, Jayasinghe, RG, Mendez, D, Wendl, MC, Clark, DJ, Newton, CJ, Ruan, Y, Reimers, MA, Pachynski, RK, Kinsinger, C, Jewell, SD, Chan, DW, Zhang, H, Chaudhuri, AA, Chheda, MG, Humphreys, BD, Mesri, M, Rodriguez, H, Hsieh, JJ, Ding, L, Chen, F. Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. Nat Commun 14(1):1681, 2023. e-Pub 2023. PMID: 36973268.
      8. Wang JM, Hong R, Demicco EG, Tan J, Lazcano R, Moreira AL, Li Y, Calinawan A, Razavian N, Schraink T, Gillette MA, Omenn GS, An E, Rodriguez H, Tsirigos A, Ruggles KV, Ding L, Robles AI, Mani DR, Rodland KD, Lazar AJ, Liu W, Fenyö D, Aguet F, Akiyama Y, Anand S, Anurag M, Babur Ö, Bavarva J, Birger C, Birrer MJ, Cantley LC, Cao S, Carr SA, Ceccarelli M, Chan DW, Chinnaiyan AM, Cho H, Chowdhury S, Cieslik MP, Clauser KR, Colaprico A, Zhou DC, Veiga Leprevost FD, Day C, Dhanasekaran SM, Domagalski MJ, Dou Y, Druker BJ, Edwards N, Ellis MJ, Selvan ME, Foltz SM, Francis A, Geffen Y, Getz G, Gonzalez Robles TJ, Gosline SJ, Gümüş ZH, Heiman DI, Hiltke T, Hostetter G, Hu Y, Huang C, Huntsman E, Iavarone A, Jaehnig EJ, Jewell SD, Ji J, Jiang W, Johnson JL, Katsnelson L, Ketchum KA, Kolodziejczak I, Krug K, Kumar-Sinha C, Lei JT, Liang W, Liao Y, Lindgren CM, Liu T, Ma W, Rodrigues FM, McKerrow W, Mesri M, Nesvizhskii AI, Newton CJ, Oldroyd R, Paulovich AG, Payne SH, Petralia F, Pugliese P, Reva B, Rykunov D, Satpathy S, Savage SR, Schadt EE, Schnaubelt M, Schürer S, Shi Z, Smith RD, Song X, Song Y, Stathias V, Storrs EP, Terekhanova NV, Thangudu RR, Thiagarajan M, Tignor N, Wang L, Wang P, Wang Y, Wen B, Wiznerowicz M, Wu Y, Wyczalkowski MA, Yao L, Yaron TM, Yi X, Zhang B, Zhang H, Zhang Q, Zhang X, Zhang Z. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell Rep Med 4(9), 2023. e-Pub 2023. PMID: 37582371.
      9. Liang, WW, Lu, RH, Jayasinghe, RG, Foltz, SM, Porta-Pardo, E, Geffen, Y, Wendl, MC, Segura Lazcano, R, Kołodziejczak, I, Song, Y, Govindan, A, Demicco, EG, Li, X, Li, Y, Sethuraman, S, Payne, SH, Fenyö, D, Rodriguez, H, Wiznerowicz, M, Shen, H, Mani, DR, Rodland, KD, Lazar, A, Robles, AI, Ding, L, Aguet, F, Akiyama, Y, An, E, Anand, S, Anurag, M, Babur, Ö, Bavarva, J, Birger, C, Birrer, MJ, Calinawan, A, Cantley, LC, Cao, S, Carr, SA, Ceccarelli, M, Chan, D, Chinnaiyan, AM, Cho, H, Chowdhury, S, Cieślik, M, Clauser, KR, Colaprico, A, Zhou, DC, da Veiga Leprevost, F, Jaehnig, EJ, Jewell, SD. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer cell 41(9):1567-1585.e7, 2023. e-Pub 2023. PMID: 37582362.
      10. Dou, Y, Katsnelson, L, Gritsenko, MA, Hu, Y, Reva, B, Hong, R, Wang, YT, Kołodziejczak, I, Lu, RH, Tsai, CF, Bu, W, Liu, W, Guo, X, An, E, Arend, RC, Bavarva, J, Chen, L, Chu, RK, Czekański, A, Davoli, T, Demicco, EG, Delair, D, Devereaux, K, Dhanasekaran, SM, Dottino, P, Dover, B, Fillmore, TL, Foxall, M, Hermann, CE, Hiltke, T, Hostetter, G, Jędryka, M, Jewell, SD, Johnson, I, Kahn, AG, Ku, AT, Kumar-Sinha, C, Kurzawa, P, Lazar, A, Segura Lazcano, R, Lei, JT, Li, Y, Liao, Y, Lih, TM, Lin, TT, Martignetti, JA, Masand, RP, Matkowski, R, McKerrow, W, Mesri, M, Clinical Proteomic Tumor Analysis Consortium. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer cell 41(9):1586-1605.e15, 2023. e-Pub 2023. PMID: 37567170.
      11. Geffen, Y, Anand, S, Akiyama, Y, Yaron, TM, Song, Y, Johnson, JL, Govindan, A, Babur, Ö, Li, Y, Huntsman, E, Wang, LB, Birger, C, Heiman, DI, Zhang, Q, Miller, M, Maruvka, Y, Haradhvala, NJ, Calinawan, A, Belkin, S, Kerelsky, A, Clauser, KR, Krug, K, Satpathy, S, Payne, SH, Mani, DR, Gillette, MA, Dhanasekaran, SM, Thiagarajan, M, Mesri, M, Rodriguez, H, Robles, AI, Carr, SA, Lazar, A, Aguet, F, Cantley, LC, Ding, L, Getz, G, An, E, Anurag, M, Bavarva, J, Birrer, MJ, Cao, S, Ceccarelli, M, Chan, DW, Chinnaiyan, AM, Cho, H, Chowdhury, S, Cieślik, M, Jaehnig, EJ, Jewell, SD. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186(18):3945-3967.e26, 2023. e-Pub 2023. PMID: 37582358.
      12. Li, Y, Porta-Pardo, E, Tokheim, C, Bailey, MH, Yaron, TM, Stathias, V, Geffen, Y, Imbach, KJ, Cao, S, Anand, S, Akiyama, Y, Liu, W, Wyczalkowski, MA, Song, Y, Storrs, E, Wendl, MC, Zhang, W, Sibai, M, Ruiz-Serra, V, Liang, WW, Terekhanova, NV, Rodrigues, FM, Clauser, KR, Heiman, DI, Zhang, Q, Aguet, F, Calinawan, A, Dhanasekaran, SM, Birger, C, Satpathy, S, Zhou, DC, Wang, LB, Baral, J, Johnson, JL, Huntsman, E, Pugliese, P, Colaprico, A, Iavarone, A, Chheda, MG, Ricketts, CJ, Fenyö, D, Payne, SH, Rodriguez, H, Robles, AI, Gillette, MA, Kumar-Sinha, C, Lazar, A, Cantley, LC, Jaehnig, EJ, Jewell, SD. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell 186(18):3921-3944.e25, 2023. e-Pub 2023. PMID: 37582357.
      13. Li, Y, Lih, TM, Dhanasekaran, SM, Mannan, R, Chen, L, Cieślik, M, Wu, Y, Lu, RH, Clark, DJ, Kołodziejczak, I, Hong, R, Chen, S, Zhao, Y, Chugh, S, Caravan, W, Naser Al Deen, N, Hosseini, N, Newton, CJ, Krug, K, Xu, Y, Cho, KC, Hu, Y, Zhang, Y, Kumar-Sinha, C, Ma, W, Calinawan, A, Wyczalkowski, MA, Wendl, MC, Wang, Y, Guo, S, Zhang, C, Le, A, Dagar, A, Hopkins, AC, Cho, H, da Veiga Leprevost, F, Jing, X, Teo, GC, Liu, W, Reimers, MA, Pachynski, RK, Lazar, A, Chinnaiyan, AM, Van Tine, BA, Zhang, B, Rodland, KD, Getz, G, Mani, DR, Wang, P, Jewell, SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L, Clinical Proteomic Tumor Analysis Consortium. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer cell 41(1):139-163.e17, 2023. e-Pub 2023. PMID: 36563681.
      14. Li, QK, Hu, Y, Chen, L, Schnaubelt, M, Cui Zhou, D, Li, Y, Lu, RH, Thiagarajan, M, Hostetter, G, Newton, CJ, Jewell, SD, Omenn, GS, Robles, AI, Mesri, M, Bathe, OF, Zhang, B, Ding, L, Hruban, RH, Chan, DW, Zhang, H. Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma. Clin Proteomics 19(1), 2022. e-Pub 2022. PMID: 36266629.
      15. Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, Krug K, Clark DJ, Schnaubelt M, Chen L, da Veiga Leprevost F, Eguez RV, Yang W, Pan J, Wen B, Dou Y, Jiang W, Liao Y, Shi Z, Terekhanova NV, Cao S, Lu RJ, Li Y, Liu R, Zhu H, Ronning P, Wu Y, Wyczalkowski MA, Easwaran H, Danilova L, Mer AS, Yoo S, Wang JM, Liu W, Haibe-Kains B, Thiagarajan M, Jewell SD, Hostetter G, Newton CJ, Li QK, Roehrl MH, Fenyo D, Wang P, Nesvizhskii AI, Mani DR, Omenn GS, Boja ES, Mesri M, Robles AI, Rodriguez H, Bathe OF, Chan DW, Hruban RH, Ding L, Zhang B, Zhang H, Clinical Proteomic Tumor Analysis Consortium. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184(19):5031-5052.e26, 2021. e-Pub 2021. PMID: 34534465.
      16. Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gumus ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur O, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyo D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA. A proteogenomic portrait of lung squamous cell carcinoma. Cell 184(16):4348-4371.e40, 2021. e-Pub 2021. PMID: 34358469.
      17. de Goede OM, Nachun DC, Ferraro NM, Gloudemans MJ, Rao AS, Smail C, Eulalio TY, Aguet F, Ng B, Xu J, Barbeira AN, Castel SE, Kim-Hellmuth S, Park Y, Scott AJ, Strober BJ, Anand S, Gabriel S, Getz GA, Graubert A, Hadley K, Handsaker RE, Huang KH, Li X, MacArthur DG, Meier SR, Nedzel JL, Nguyen DT, Segrè AV, Todres E, Balliu B, Bonazzola R, Brown A, Conrad DF, Cotter DJ, Cox N, Das S, Dermitzakis ET, Einson J, Engelhardt BE, Eskin E, Flynn ED, Fresard L, Gamazon ER, Garrido-Martín D, Gay NR, Guigó R, Hamel AR, He Y, Hoffman PJ, Hormozdiari F, Hou L, Jo B, Kasela S, Kashin S, Kellis M, Kwong A, Li X, Liang Y, Mangul S, Mohammadi P, Muñoz-Aguirre M, Nobel AB, Oliva M, Park Y, Parsana P, Reverter F, Rouhana JM, Sabatti C, Saha A, Stephens M, Stranger BE, Teran NA, Viñuela A, Wang G, Wright F, Wucher V, Zou Y, Ferreira PG, Li G, Melé M, Yeger-Lotem E, Bradbury D, Krubit T, McLean JA, Qi L, Robinson K, Roche NV, Smith AM, Tabor DE, Undale A, Bridge J, Brigham LE, Foster BA, Gillard BM, Hasz R, Hunter M, Johns C, Johnson M, Karasik E, Kopen G, Leinweber WF, McDonald A, Moser MT, Myer K, Ramsey KD, Roe B, Shad S, Thomas JA, Walters G, Washington M, Wheeler J, Jewell SD, Rohrer DC, Valley DR, Davis DA, Mash DC, Barcus ME, Branton PA, Sobin L, Barker LK, Gardiner HM, Mosavel M, Siminoff LA, Flicek P, Haeussler M, Juettemann T, Kent W, Lee CM, Powell CC, Rosenbloom KR, Ruffier M, Sheppard D, Taylor K, Trevanion SJ, Zerbino DR, Abell NS, Akey J, Chen L, Demanelis K, Doherty JA, Feinberg AP, Hansen KD, Hickey PF, Jasmine F, Jiang L, Kaul R, Kibriya MG, Li JB, Li Q, Lin S, Linder SE, Pierce BL, Rizzardi LF, Skol AD, Smith KS, Snyder M, Stamatoyannopoulos J, Tang H, Wang M, Carithers LJ, Guan P, Koester SE, Little A, Moore HM, Nierras CR, Rao AK, Vaught JB, Volpi S, Brown CD, Wen X, Hall IM, Battle A, Lappalainen T, Im HK, Ardlie KG, Mostafavi S, Quertermous T, Kirkegaard K, Montgomery SB, GTEx Consortium. Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease. Cell 184(10):2633-2648.e19, 2021. e-Pub 2021. PMID: 33864768.
      18. Bagchi A, Madaj Z, Engel KB, Guan P, Rohrer DC, Valley DR, Wolfrum E, Feenstra K, Roche N, Hostetter G, Moore HM, Jewell SD. Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry. J Histochem Cytochem 69(5):297-320, 2021. e-Pub 2021. PMID: 33641490.
      19. Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Li Y, da Veiga Leprevost F, Jaehnig EJ, Lei JT, Wen B, Schnaubelt M, Krug K, Song X, Cieslik M, Chang HY, Wyczalkowski MA, Li K, Colaprico A, Li QK, Clark DJ, Hu Y, Cao L, Pan J, Wang Y, Cho KC, Shi Z, Liao Y, Jiang W, Anurag M, Ji J, Yoo S, Zhou DC, Liang WW, Wendl M, Vats P, Carr SA, Mani DR, Zhang Z, Qian J, Chen XS, Pico AR, Wang P, Chinnaiyan AM, Ketchum KA, Kinsinger CR, Robles AI, An E, Hiltke T, Mesri M, Thiagarajan M, Weaver AM, Sikora AG, Lubinski J, Wierzbicka M, Wiznerowicz M, Satpathy S, Gillette MA, Miles G, Ellis MJ, Omenn GS, Rodriguez H, Boja ES, Dhanasekaran SM, Ding L, Nesvizhskii AI, El-Naggar AK, Chan DW, Zhang H, Zhang B, Agarwal A, Anderson ML, Avanessian SC, Avtonomov D, Bathe OF, Birger C, Birrer MJ, Blumenberg L, Bocik WE, Borate U, Borucki M, Burke MC, Cai S, Calinawan AP, Cerda S, Charamut A, Chen LS, Chowdhury S, Clauser KR, Culpepper H, Czernicki T, D'Angelo F, Day J, Young SD, Demir E, Ding F, Domagalski MJ, Dort JC, Druker B, Duffy E, Dyer M, Edwards NJ, Elburn K, Ermakova TS, Fenyo D, Ferrarotto R, Francis A, Gabriel S, Garofano L, Geffen Y, Getz G, Goldthwaite CA, Hannick LI, Hariharan P, Hayes DN, Heiman D, Hindenach B, Hoadley KA, Hostetter G, Hyrcza M, Jewell SD, Jones CD, Kane M, Karz A, Kothadia RB, Krek A, Kumar-Sinha C, Liu T, Liu H, Ma W, Malc E, Malovannaya A, Mareedu S, Markey SP, Marrero-Oliveras A, Maunganidze N, McDermott JE, McGarvey PB, McGee J, Mieczkowski P, Migliozzi S, Montgomery R, Newton CJ, Ozbek U, Paulovich AG, Payne SH, Pazardzhikliev DD, Perou AM, Petralia F, Petrenko L, Piehowski PD, Placantonakis D, Polonskaya L, Ponomareva EV, Potapova O, Qi L, Qu N, Ramkissoon S, Reva B, Richey S, Robinson K, Roche N, Rodland K, Rohrer DC, Rykunov D, Schadt EE, Shi Y, Shutack Y, Singh S, Skelly T, Smith R, Sokoll LJ, Stawicki J, Stein SE, Suh J, Szopa W, Tabor D, Tan D, Tansil D, Teo GC, Thangudu RR, Tognon C, Traer E, Tsang S, Tyner J, Um KS, Valley DR, Vasilev LV, Vatanian N, Velvulou U, Vernon M, Westbrook TF, Whiteaker JR, Wu Y, Xu M, Yao L, Yi X, Yu F, Zaalishvili K, Zakhartsev Y, Zelt R, Zhao G, Zhu J, Clinical Proteomic Tumor Analysis Consortium. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell 39(3):361-379.e16, 2021. e-Pub 2021. PMID: 33417831.
      20. Wang L, Karpova A, Gritsenko MA, Kyle JE, Cao S, Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang W, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Zhou DC, Ji J, Tsai C, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schürer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyö D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L, Agarwal A, Amin M, An E, Anderson ML, Andrews DW, Bauer T, Birger C, Birrer MJ, Blumenberg L, Bocik WE, Borate U, Borucki M, Burke MC, Cai S, Calinawan AP, Carr SA, Cerda S, Chan DW, Charamut A, Chen LS, Chesla D, Chinnaiyan AM, Chowdhury S, Cieślik MP, Clark DJ, Culpepper H, Czernicki T, D'Angelo F, Day J, Young SD, Demir E, Dhanasekaran SM, Dhir R, Domagalski MJ, Druker B, Duffy E, Dyer M, Edwards NJ, Edwards R, Elburn K, Ellis MJ, Eschbacher J, Francis A, Gabriel S, Gabrovski N, Garofano L, Getz G, Gillette MA, Godwin AK, Golbin D, Hanhan Z, Hannick LI, Hariharan P, Hindenach B, Hoadley KA, Hostetter G, Huang C, Jaehnig E, Jewell SD, Ji N, Jones CD, Karz A, Kaspera W, Kim L, Kothadia RB, Kumar-Sinha C, Lei J, Leprevost FD, Li K, Liao Y, Lilly J, Liu H, Lubínski J, Madan R, Maggio W, Malc E, Malovannaya A, Mareedu S, Markey SP, Marrero-Oliveras A, Martinez N, Maunganidze N, McDermott JE, McGarvey PB, McGee J, Mieczkowski P, Migliozzi S, Modugno F, Montgomery R, Newton CJ, Omenn GS, Ozbek U, Paklina OV, Paulovich AG, Perou AM, Pico AR, Piehowski PD, Placantonakis DG, Polonskaya L, Potapova O, Pruetz B, Qi L, Ramkissoon S, Resnick A, Richey S, Riggins G, Robinson K, Roche N, Rohrer DC, Rood BR, Rossell L, Savage SR, Schadt EE, Shi Y, Shi Z, Shutack Y, Singh S, Skelly T, Sokoll LJ, Stawicki J, Stein SE, Suh J, Szopa W, Tabor D, Tan D, Tansil D, Thangudu RR, Tognon C, Traer E, Tsang S, Tyner J, Um KS, Valley DR, Vasaikar S, Vatanian N, Velvulou U, Vernon M, Wan W, Wang J, Webster A, Wen B, Whiteaker JR, Wilson GD, Zakhartsev Y, Zelt R, Zhang H, Zhang L, Zhang Z, Zhao G, Zhu J. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 39(4):509-528, 2021. e-Pub 2021. PMID: 33577785.
      21. Jiang L, Wang M, Lin S, Jian R, Li X, Chan J, Dong G, Fang H, Robinson AE, Snyder MP, Aguet F, Anand S, Ardlie KG, Gabriel S, Getz G, Graubert A, Hadley K, Handsaker RE, Huang KH, Kashin S, MacArthur DG, Meier SR, Nedzel JL, Nguyen DY, Segrè AV, Todres E, Balliu B, Barbeira AN, Battle A, Bonazzola R, Brown A, Brown CD, Castel SE, Conrad D, Cotter DJ, Cox N, Das S, de Goede OM, Dermitzakis ET, Engelhardt BE, Eskin E, Eulalio TY, Ferraro NM, Flynn E, Fresard L, Gamazon ER, Garrido-Martín D, Gay NR, Guigó R, Hamel AR, He Y, Hoffman PJ, Hormozdiari F, Hou L, Im HK, Jo B, Kasela S, Kellis M, Kim-Hellmuth S, Kwong A, Lappalainen T, Li X, Liang Y, Mangul S, Mohammadi P, Montgomery SB, Muñoz-Aguirre M, Nachun DC, Nobel AB, Oliva M, Park Y, Park Y, Parsana P, Reverter F, Rouhana JM, Sabatti C, Saha A, Skol AD, Stephens M, Stranger BE, Strober BJ, Teran NA, Viñuela A, Wang G, Wen X, Wright F, Wucher V, Zou Y, Ferreira PG, Li G, Melé M, Yeger-Lotem E, Barcus ME, Bradbury D, Krubit T, McLean JA, Qi L, Robinson K, Roche NV, Smith AM, Sobin L, Tabor DE, Undale A, Bridge J, Brigham LE, Foster BA, Gillard BM, Hasz R, Hunter M, Johns C, Johnson M, Karasik E, Kopen G, Leinweber WF, McDonald A, Moser MT, Myer K, Ramsey KD, Roe B, Shad S, Thomas JA, Walters G, Washington M, Wheeler J, Jewell SD, Rohrer DC, Valley DR, Davis DA, Mash DC, Branton PA, Barker LK, Gardiner HM, Mosavel M, Siminoff LA, Flicek P, Haeussler M, Juettemann T, Kent W, Lee CM, Powell CC, Rosenbloom KR, Ruffier M, Sheppard D, Taylor K, Trevanion SJ, Zerbino DR, Abell NS, Akey J, Chen L, Demanelis K, Doherty JA, Feinberg AP, Hansen KD, Hickey PF, Jasmine F, Kaul R, Kibriya MG, Li JB, Li Q, Linder SE, Pierce BL, Rizzardi LF, Smith KS, Stamatoyannopoulos J, Tang H, Carithers LJ, Guan P, Koester SE, Little A, Moore HM, Nierras CR, Rao AK, Vaught JB, Volpi S, GTEx Consortium. A Quantitative Proteome Map of the Human Body. Cell 183(1):269-283.e19, 2020. e-Pub 2020. PMID: 32916130.
      22. Demanelis K, Jasmine F, Chen LS, Chernoff M, Tong L, Delgado D, Zhang C, Shinkle J, Sabarinathan M, Lin H, Ramirez E, Oliva M, Kim-Hellmuth S, Stranger BE, Lai T, Aviv A, Ardlie KG, Aguet F, Ahsan H, GTEx Consortium, Doherty JA, Kibriya MG, Pierce BL. Determinants of telomere length across human tissues. Science 369(6509), 2020. e-Pub 2020. PMID: 32913074.
      23. The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369(6509):1318-1330, 2020. e-Pub 2020. PMID: 32913098.
      24. Oliva M, Munoz-Aguirre M, Kim-Hellmuth S, Wucher V, Gewirtz ADH, Cotter DJ, Parsana P, Kasela S, Balliu B, Vinuela A, Castel SE, Mohammadi P, Aguet F, Zou Y, Khramtsova EA, Skol AD, Garrido-Martin D, Reverter F, Brown A, Evans P, Gamazon ER, Payne A, Bonazzola R, Barbeira AN, Hamel AR, Martinez-Perez A, Soria JM, GTEx Consortium, Pierce BL, Stephens M, Eskin E, Dermitzakis ET, Segre AV, Im HK, Engelhardt BE, Ardlie KG, Montgomery SB, Battle AJ, Lappalainen T, Guigo R, Stranger BE. The impact of sex on gene expression across human tissues. Science 369(6509), 2020. e-Pub 2020. PMID: 32913072.
      25. Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, Gumus ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Fenyo D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell 182(1):200-225.e35, 2020. e-Pub 2020. PMID: 32649874.
      26. Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, Karpova A, Petyuk VA, Savage SR, Satpathy S, Liu W, Wu Y, Tsai CF, Wen B, Li Z, Cao S, Moon J, Shi Z, Cornwell M, Wyczalkowski MA, Chu RK, Vasaikar S, Zhou H, Gao Q, Moore RJ, Li K, Sethuraman S, Monroe ME, Zhao R, Heiman D, Krug K, Clauser K, Kothadia R, Maruvka Y, Pico AR, Oliphant AE, Hoskins EL, Pugh SL, Beecroft SJI, Adams DW, Jarman JC, Kong A, Chang HY, Reva B, Liao Y, Rykunov D, Colaprico A, Chen XS, Czekanski A, Jedryka M, Matkowski R, Wiznerowicz M, Hiltke T, Boja E, Kinsinger CR, Mesri M, Robles AI, Rodriguez H, Mutch D, Fuh K, Ellis MJ, DeLair D, Thiagarajan M, Mani DR, Getz G, Noble M, Nesvizhskii AI, Wang P, Anderson ML, Levine DA, Smith RD, Payne SH, Ruggles KV, Rodland KD, Ding L, Zhang B, Liu T, Fenyo D, Agarwal A, Anurag M, Avtonomov D, Birger C, Birrer MJ, Boca SM, Bocik WE, Borate U, Borucki M, Burke MC, Cai S, Calinawan A, Carr SA, Carter S, Castro P, Cerda S, Chaikin M, Chan DW, Chan D, Charamut A, Chen F, Chen J, Chen L, Chen LS, Chesla D, Chheda MG, Chinnaiyan AM, Chowdhury S, Cieslik MP, Clark DJ, Cottingham S, Culpepper H, Day J, Young SD, Demir E, Dhanasekaran SM, Dhir R, Domagalski MJ, Dottino P, Druker B, Duffy E, Dyer M, Edwards NJ, Edwards R, Elburn K, Field JB, Francis A, Gabriel S, Geffen Y, Geiszler D, Gillette MA, Godwin AK, Grady P, Hannick L, Hariharan P, Hilsenbeck S, Hindenach B, Hoadley KA, Hong R, Hostetter G, Hsieh JJ, Hu Y, Ittmann MM, Jaehnig E, Jewell SD, Ji J, Jones CD, Karabon R, Ketchum KA, Khan M, Kim B, Krek A, Krubit T, Kumar-Sinha C, Leprevost FD, Lewis M, Li QK, Li Y, Liu H, Lubinski J, Ma W, Madan R, Malc E, Malovannaya A, Mareedu S, Markey SP, Marrero-Oliveras A, Martignetti J, McDermott J, McGarvey PB, McGee J, Mieczkowski P, Modugno F, Montgomery R, Newton CJ, Omenn GS, Paulovich AG, Perou AM, Petralia F, Piehowski P, Polonskaya L, Qi L, Richey S, Robinson K, Roche N, Rohrer DC, Schadt EE, Schnaubelt M, Shi Y, Skelly T, Sokoll LJ, Song X, Stein SE, Suh J, Tan D, Tansil D, Teo GC, Thangudu RR, Tognon C, Traer E, Tyner J, Um KS, Valley DR, Vatanian N, Vats P, Velvulou U, Vernon M, Wang L, Wang Y, Webster A, Westbrook T, Wheeler D, Whiteaker JR, Wilson GD, Zakhartsev Y, Zelt R, Zhang H, Zhang Y, Zhang Z, Zhao G. Proteogenomic Characterization of Endometrial Carcinoma. Cell 180(4):729-748.e26, 2020. e-Pub 2020. PMID: 32059776.
      27. Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, da Veiga Leprevost F, Reva B, Lih TM, Chang HY, Ma W, Huang C, Ricketts CJ, Chen L, Krek A, Li Y, Rykunov D, Li QK, Chen LS, Ozbek U, Vasaikar S, Wu Y, Yoo S, Chowdhury S, Wyczalkowski MA, Ji J, Schnaubelt M, Kong A, Sethuraman S, Avtonomov DM, Ao M, Colaprico A, Cao S, Cho KC, Kalayci S, Ma S, Liu W, Ruggles K, Calinawan A, Gumus ZH, Geiszler D, Kawaler E, Teo GC, Wen B, Zhang Y, Keegan S, Li K, Chen F, Edwards N, Pierorazio PM, Chen XS, Pavlovich CP, Hakimi AA, Brominski G, Hsieh JJ, Antczak A, Omelchenko T, Lubinski J, Wiznerowicz M, Linehan WM, Kinsinger CR, Thiagarajan M, Boja ES, Mesri M, Hiltke T, Robles AI, Rodriguez H, Qian J, Fenyo D, Zhang B, Ding L, Schadt E, Chinnaiyan AM, Zhang Z, Omenn GS, Cieslik M, Chan DW, Nesvizhskii AI, Wang P, Zhang H, Hashimi AS, Pico AR, Karpova A, Charamut A, Paulovich AG, Perou AM, Malovannaya A, Marrero-Oliveras A, Agarwal A, Hindenach B, Pruetz B, Kim B, Druker BJ, Newton CJ, Birger C, Jones CD, Tognon C, Mani DR, Valley DR, Rohrer DC, Zhou DC, Tansil D, Chesla D, Heiman D, Wheeler D, Tan D, Chan D, Demir E, Malc E, Modugno F, Getz G, Hostetter G, Wilson GD, Hart GW, Zhu H, Liu H, Culpepper H, Sun H, Zhou H, Day J, Suh J, Huang J, McDermott J, Whiteaker JR, Tyner JW, Eschbacher J, Chen J, McGee J, Zhu J, Ketchum KA, Rodland KD, Clauser K, Robinson K, Krug K, Hoadley KA, Um KS, Elburn K, Holloway K, Wang L, Blumenberg L, Hannick L, Qi L, Sokoll LJ, Cornwell M, Loriaux M, Domagalski MJ, Gritsenko MA, Anderson M, Monroe ME, Ellis MJ, Dyer M, Anurag M, Burke MC, Borucki M, Gillette MA, Birrer MJ, Lewis M, Ittmann MM, Smith M, Vernon M, Chaikin M, Chheda MG, Khan M, Roche N, Edwards NJ, Vatanian N, Tignor N, Beckmann N, Grady P, Castro P, Piehowski P, McGarvey PB, Mieczkowski P, Hariharan P, Gao Q, Dhir R, Kothadia RB, Thangudu RR, Montgomery R, Jayasinghe RG, Smith RD, Edwards R, Zelt R, Bremner R, Liu R, Hong R, Mareedu S, Payne SH, Cottingham S, Markey SP, Jewell SD, Patel S, Satpathy S, Richey S, Davies SR, Cai S, Boca SM, Patil S, Sengupta S, Carter S, Gabriel S, Thomas SN, Young SD, Stein SE, Carr SA, Foltz SM, Hilsenbeck S, Krubit T, Liu T, Skelly T, Westbrook T, Borate U, Velvulou U, Petyuk VA, Bocik WE, Chen X, Shi Y, Geffen Y, Lu Y, Wang Y, Maruvka Y, Li Z, Shi Z, Tu Z, Clinical Proteomic Tumor Analysis Consortium. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell 179(4):964-983.e31, 2019. e-Pub 2019. PMID: 31675502.
      28. Carithers LJ, Agarwal R, Guan P, Odeh H, Sachs MC, Engel KB, Greytak SR, Barcus M, Soria C, Lih CJ, Williams PM, Branton PA, Sobin L, Fombonne B, Bocklage T, Andry C, Duffy ER, Sica G, Dhir R, Jewell S, Roche N, Moore HM. The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality. Arch Pathol Lab Med 143(9):1106-1118, 2019. e-Pub 2019. PMID: 30785788.
      29. Mathieson W, Mommaerts K, Trouet JM, Mathay C, Guan P, Carithers LJ, Rohrer D, Valley DR, Blanski A, Jewell S, Moore HM, Betsou F. Cold Ischemia Score: An mRNA Assay for the Detection of Extended Cold Ischemia in Formalin-Fixed, Paraffin-Embedded Tissue. J Histochem Cytochem 67(3):159-168, 2019. e-Pub 2019. PMID: 30562131.
      30. Ammerlaan W, Trouet J, Sachs MC, Guan P, Carithers L, Lambert P, Frasquilho S, Antunes L, Kofanova O, Rohrer D, Valley DR, Blanski A, Jewell S, Moore H, Betsou F. Small Nucleolar RNA Score: An Assay to Detect Formalin-Overfixed Tissue. Biopreserv Biobank 16(6):467-476, 2018. e-Pub 2018. PMID: 30234371.
      31. De Vries RG, Ryan KA, Gordon L, Krenz CD, Tomlinson T, Jewell S, Kim SYH. Biobanks and the Moral Concerns of Donors: A Democratic Deliberation. Qual Health Res 29(13):1942-1953, 2018. e-Pub 2018. PMID: 30095038.
      32. Tomlinson T, De Vries RG, Kim HM, Gordon L, Ryan KA, Krenz CD, Jewell S, Kim SYH. Effect of deliberation on the public's attitudes toward consent policies for biobank research. Eur J Hum Genet 26(2):176-185, 2018. e-Pub 2018. PMID: 29348694.
      33. McCall SJ, Branton PA, Blanc VM, Dry SM, Gastier-Foster JM, Harrison JH, Jewell SD, Dash RC, Obeng RC, Rose J, Mateski DL, Liubinskas A, Robb JA, Ramirez NC, Shea K. The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years. Biopreserv Biobank 16(1):16-22, 2018. e-Pub 2018. PMID: 29394087.
      34. Manojlovic Z, Christofferson A, Liang WS, Aldrich J, Washington M, Wong S, Rohrer D, Jewell S, Kittles RA, Derome M, Auclair D, Craig DW, Keats J, Carpten JD. Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases. PLoS Genet 13(11):e1007087, 2017. e-Pub 2017. PMID: 29166413.
      35. Saha A, Kim Y, Gewirtz ADH, Jo B, Gao C, McDowell IC, GTEx Consortium, Engelhardt BE, Battle A. Co-expression networks reveal the tissue-specific regulation of transcription and splicing. Genome Res 27(11):1843-1858, 2017. e-Pub 2017. PMID: 29021288.
      36. Yang F, Wang J, GTEx Consortium, Pierce BL, Chen LS. Identifying cis-mediators for trans-eQTLs across many human tissues using genomic mediation analysis. Genome Res 27(11):1859-1871, 2017. e-Pub 2017. PMID: 29021290.
      37. GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 550(7675):204-213, 2017. e-Pub 2017. PMID: 29022597.
      38. Tan MH, Li Q, Shanmugam R, Piskol R, Kohler J, Young AN, Liu KI, Zhang R, Ramaswami G, Ariyoshi K, Gupte A, Keegan LP, George CX, Ramu A, Huang N, Pollina EA, Leeman DS, Rustighi A, Goh YPS, GTEx Consortium, Chawla A, Del Sal G, Peltz G, Brunet A, Conrad DF, Samuel CE, O'Connell MA, Walkley CR, Nishikura K, Li JB. Dynamic landscape and regulation of RNA editing in mammals. Nature 550(7675):249-254, 2017. e-Pub 2017. PMID: 29022589.
      39. Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, GTEx Consortium, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG. Landscape of X chromosome inactivation across human tissues. Nature 550(7675):244-248, 2017. e-Pub 2017. PMID: 29022598.
      40. Li X, Kim Y, Tsang EK, Davis JR, Damani FN, Chiang C, Hess GT, Zappala Z, Strober BJ, Scott AJ, Li A, Ganna A, Bassik MC, Merker JD, GTEx Consortium, Hall IM, Battle A, Montgomery SB. The impact of rare variation on gene expression across tissues. Nature 550(7675):239-243, 2017. e-Pub 2017. PMID: 29022581.
      41. Carithers LJ, Ardlie K, Barcus M, Branton PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J, Gelfand ET, Guan P, Korzeniewski GE, Lockhart NC, Rabiner CA, Rao AK, Robinson KL, Roche NV, Sawyer SJ, Segre AV, Shive CE, Smith AM, Sobin LH, Undale AH, Valentino KM, Vaught J, Young TR, Moore HM, GTEx Consortium. A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project. Biopreserv Biobank 13(5):311-9, 2015. e-Pub 2015. PMID: 26484571.
      42. Consortium TG, Ardlie KG, Deluca DS, Segrè AV, Sullivan TJ, Young TR, Gelfand ET, Trowbridge CA, Maller JB, Tukiainen T, Lek M, Ward LD, Kheradpour P, Iriarte B, Meng Y, Palmer CD, Esko T, Winckler W, Hirschhorn JN, Kellis M, MacArthur DG, Getz G, Shabalin AA, Li G, Zhou Y, Nobel AB, Rusyn I, Wright FA, Lappalainen T, Ferreira PG, Ongen H, Rivas MA, Battle A, Mostafavi S, Monlong J, Sammeth M, Mele M, Reverter F, Goldmann JM, Koller D, Guigó R, McCarthy MI, Dermitzakis ET, Gamazon ER, Im HK, Konkashbaev A, Nicolae DL, Cox NJ, Flutre T, Wen X, Stephens M, Pritchard JK, Tu Z, Zhang B, Huang T, Long Q, Lin L, Yang J, Zhu J, Liu J, Brown A, Mestichelli B, Tidwell D, Lo E, Salvatore M, Shad S, Thomas JA, Lonsdale JT, Moser MT, Gillard BM, Karasik E, Ramsey K, Choi C, Foster BA, Syron J, Fleming J, Magazine H, Hasz R, Walters GD, Bridge JP, Miklos M, Sullivan S, Barker LK, Traino HM, Mosavel M, Siminoff LA, Valley DR, Rohrer DC, Jewell SD, Branton PA, Sobin LH, Barcus M, Qi L, McLean J, Hariharan P, Um KS, Wu S, Tabor D, Shive C, Smith AM, Buia SA, Undale AH, Robinson KL, Roche N, Valentino KM, Britton A, Burges R, Bradbury D, Hambright KW, Seleski J, Korzeniewski GE, Erickson K, Marcus Y, Tejada J, Taherian M, Lu C, Basile M, Mash DC, Volpi S, Struewing JP, Temple GF, Boyer J, Colantuoni D, Little R, Koester S, Carithers LJ, Moore HM, Guan P, Compton C, Sawyer SJ, Demchok JP, Vaught JB, Rabiner CA, Lockhart NC, Ardlie KG, Getz G, Wright FA, Kellis M, Volpi S, Dermitzakis ET. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348(6235):648-60, 2015. e-Pub 2015. PMID: 25954001.
      43. Robb JA, Gulley ML, Fitzgibbons PL, Kennedy MF, Cosentino LM, Washington K, Dash RC, Branton PA, Jewell SD, Lapham RL. A call to standardize preanalytic data elements for biospecimens. Arch Pathol Lab Med 138(4):526-37, 2014. e-Pub 2014. PMID: 23937609.
      44. Hostetter G, Collins E, Varlan P, Edewaard E, Harbach PR, Hudson EA, Feenstra KJ, Turner LM, Berghuis BD, Resau JH, Jewell SD. Veterinary and human biobanking practices: enhancing molecular sample integrity. Vet Pathol 51(1):270-80, 2013. e-Pub 2013. PMID: 24227009.
      45. Jewell SD, Cordial CR. Silver Staining of Nucleolar Organizer Regions. J Histotechnol 19(3):241-256, 2013. e-Pub 2013.
      46. Resau JH, Ho NT, Dykema K, Faber MS, Busik JV, Nickolov RZ, Furge KA, Paneth N, Jewell S, Khoo SK. Evaluation of sex-specific gene expression in archived dried blood spots (DBS). Int J Mol Sci 13(8):9599-9608, 2012. e-Pub 2012. PMID: 22949818.
      47. Fagundes CP, Glaser R, Johnson SL, Andridge RR, Yang EV, Di Gregorio MP, Chen M, Lambert DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK. Basal cell carcinoma: stressful life events and the tumor environment. Arch Gen Psychiatry 69(6):618-26, 2012. e-Pub 2012. PMID: 22664550.
      48. Jewell SD. Perspective on Biorepository Return of Results and Incidental Findings. Min JL SCI & TECH 13(2), 2012. e-Pub 2012.
      49. Edelman MJ, Hodgson L, Wang X, Christenson R, Jewell S, Vokes E, Kratzke R. Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. J Thorac Oncol 6(11):1902-6, 2011. e-Pub 2011. PMID: 21964530.
      50. Glaser R, Andridge R, Yang EV, Shana'ah AY, Di Gregorio M, Chen M, Johnson SL, De Renne LA, Lambert DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK. Tumor site immune markers associated with risk for subsequent basal cell carcinomas. PLoS One 6(9):e25160, 2011. e-Pub 2011. PMID: 21980389.
      51. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119(2):92-101, 2011. e-Pub 2011. PMID: 21433001.
      52. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J. Biospecimen reporting for improved study quality (BRISQ). J Proteome Res 10(8):3429-38, 2011. e-Pub 2011. PMID: 21574648.
      53. Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA. Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol 29(16):2282-90, 2011. e-Pub 2011. PMID: 21519016.
      54. Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP, Greenspan R, Hainaut P, Hayes DF, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J. Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank 9(1):57-70, 2011. e-Pub 2011. PMID: 21826252.
      55. Hait WN, Khleif SN, Doroshow JH, Gutman SI, Barker PE, Dracopoli NC, Gutierrez A, Skates SJ, Austin MJ, Bast RC, Becker RL, Berry DA, Bradley LA, Bross PF, Chang M, Clark AM, Devanarayan V, Dressler LG, Endres DB, Enns RK, Frullo FJ, Harper CC, Hayes DF, Hinestrosa M, Hinman L, Hruszkewycz A, Huang PS, Jessup J, Juweid ME, Kalush F, Kaul KL, Kelloff G, Klee GG, Koch WH, Lemery S, Levy JB, Mansfield E, Maurey KM, Moseley GB, Naples R, Omel JP, Orr MS, Pennello GA, Pignato WJ, Ransohoff DF, Reid LH, Rodriguez H, Schilsky RL, Schueren R, Simon RM, Sluss PM, Sninsky JJ, Srivastava S, Taube SE, Taylor JM, van't Veer LJ, Vishnuvajjala L, Wang S, Warrington JA, Watson MS, Weiner RS, Yost J, Rajagopal G, Buetow KH, Tong W, Tucker-Kellogg G, Beck J, Bryant BM, Crichton D, Kim P, McIntosh MW, O'Leary T, Orr MS, Saltz JH, Shih WJ, Siemers N, Speakman J, Spears P, Srivastava S, Stancampiano BA, Zhang Z, Zujewski J, Compton C, Holloway B, Jewell SD, Mansfield E, Blanchard KL, Cosentino L, David KA, Mars MD, Dressler LG, Fore IM, Goldman P, Hammond EH, Hegele RG, Juhl HH, Lubensky IA, Miller GA, Mullaney BP, Philip R, Qualman SJ, Rohlfs EM, Sobel ME, Stern HM, Thompson EA, Demetri GD, Dhingra K, Kelloff GJ, Pazdur R, Adelman MJ, Alexander J, Barrett J, Chang DD, Engel JM, Geoghegan C, Grayzel DS, Grochow LB, Johnston J, Kenkare-Mitra S, Pensak D, Spinella DG, Woollett GR. AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin Cancer Res 16(13):3299-318, 2010. e-Pub 2010. PMID: 20501613.
      56. Bertagnolli MM, Warren RS, Niedzwiecki D, Mueller E, Compton CC, Redston M, Hall M, Hahn HP, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Loda M. p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. Clin Cancer Res 15(6):2116-22, 2009. e-Pub 2009. PMID: 19276255.
      57. Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol 27(11):1814-21, 2009. e-Pub 2009. PMID: 19273709.
      58. Leyland-Jones BR, Ambrosone CB, Bartlett J, Ellis MJ, Enos RA, Raji A, Pins MR, Zujewski JA, Hewitt SM, Forbes JF, Abramovitz M, Braga S, Cardoso F, Harbeck N, Denkert C, Jewell SD. Recommendations for collection and handling of specimens from group breast cancer clinical trials. J Clin Oncol 26(34):5638-44, 2008. e-Pub 2008. PMID: 18955459.
      59. Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 10(5):415-23, 2008. e-Pub 2008. PMID: 18687792.
      60. Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJ. Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203. J Clin Oncol 26(6):848-55, 2008. e-Pub 2008. PMID: 18281656.
      61. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66(21):10357-64, 2006. e-Pub 2006. PMID: 17079456.
      62. Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 34(3):842-9, 2006. e-Pub 2006. PMID: 16521279.
      63. Redston M, Compton CC, Miedema BW, Niedzwiecki D, Dowell JM, Jewell SD, Fleshman JM, Bem J, Mayer RJ, Bertagnolli MM. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol 24(6):878-83, 2006. e-Pub 2006. PMID: 16418493.
      64. Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S, Dhabhar FS. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 97(23):1760-7, 2005. e-Pub 2005. PMID: 16333031.
      65. Jewell SD, Monovich LC, Edgerton S, Schilsky RL, Dressler LG. Biospecimen Banking, Standardization, and Lessons Learned from the Cancer and Leukemia Group B Pathology Coordinating Office. Semin Breast Dis 8(2):93-99, 2005. e-Pub 2005.
      66. Chen M, Deng A, Crowson AN, Srinivasan M, Yearsley KH, Jewell S, Morrison C, Long S, Werling R, Magro C. Assessment of T-cell clonality via T-cell receptor-gamma rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay. Appl Immunohistochem Mol Morphol 12(4):373-9, 2004. e-Pub 2004. PMID: 15536341.
      67. Jewell SD, Srinivasan M, McCart LM, Williams N, Grizzle WH, LiVolsi V, MacLennan G, Sedmak DD. Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. Am J Clin Pathol 118(5):733-41, 2002. e-Pub 2002. PMID: 12428794.
      68. Srinivasan M, Gienapp IE, Stuckman SS, Rogers CJ, Jewell SD, Kaumaya PT, Whitacre CC. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28. J Immunol 169(4):2180-8, 2002. e-Pub 2002. PMID: 12165548.
      69. Schilsky RL, Dressler LM, Bucci D, Monovich L, Jewell S, Suster S, Caligiuri MA, Kantoff PW, Compton C. Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories. Clin Cancer Res 8(5):943-8, 2002. e-Pub 2002. PMID: 12006505.
      70. Srinivasan M, Jewell SD. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology 61(4):284-92, 2001. e-Pub 2001. PMID: 11721175.
      71. Srinivasan M, Jewell SD. Quantitative estimation of PCNA, c-myc, EGFR and TGF-α in oral submucous fibrosis — an immunohistochemical study. Oral Oncol 37(5):461-7, 2001. e-Pub 2001. PMID: 11377235.
      72. Comas TC, Tai T, Kimmel D, Scheithauer BW, Burger PC, Pearl DK, Jewell SD, Yates AJ. Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors. Neuro Oncol 1(4):261-7, 1999. e-Pub 1999. PMID: 11550317.
      73. Jewell SD, Gienapp IE, Cox KL, Whitacre CC. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy. Immunol Cell Biol 76(1):74-82, 1998. e-Pub 1998. PMID: 9553779.
      74. Kannan R, Bijur GN, Mallery SR, Beck FM, Sabourin CL, Jewell SD, Schuller DE, Stoner GD. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82(1):69-74, 1996. e-Pub 1996. PMID: 8843456.
      75. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 158(1):253-64, 1994. e-Pub 1994. PMID: 7916267.
      76. Whitacre CC, Gienapp IE, Cox K, Javed N, Meyer A, Jewell SD, Fuller K, Bitar D. Oral tolerance as a therapeutic approach to autoimmune disease. Mucosal Immunol 1:3-5, 1993. e-Pub 1993.
      77. Whitacre C, Apseloff G, Cox K, Matkovic V, Jewell S, Gerber N. Suppression of experimental autoimmune encephalomyelitis by gallium nitrate. J Neuroimmunol 39(1-2):175-81, 1992. e-Pub 1992. PMID: 1377710.
      78. Tuttle SE, Jewell SD, Mojzisik CM, Hinkle GH, Colcher D, Schlom J, Martin EW. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: Comparison of in vivo gamma probe counts with in vitro MAb radiolocalization. Int J Cancer 42(3):352-8, 1988. e-Pub 1988. PMID: 3417363.
      79. Oredipe OA, Barth RF, Tuttle SE, Adams DM, Sautins I, Bucci DM, Mojzisik CM, Hinkle GH, Jewell S, Steplewski Z, Thurston MO, Martin Jr EW. Limits of sensitivity for the radioimmunodetection of colon cancer by means of a hand held gamma probe. Int J Rad Appl Instrum B 15(6):595-603, 1988. e-Pub 1988. PMID: 3251894.
      80. Goodwin RA, Tuttle SE, Bucci DM, Jewell SD, Martin EW, Steplewski Z. Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A. Am J Clin Pathol 88(4):462-7, 1987. e-Pub 1987. PMID: 3310608.

      Review Articles

      1. Li Y, Dou Y, Veiga Leprevost FD, Geffen Y, Calinawan AP, Aguet F, Akiyama Y, Anand S, Birger C, Cao S, Chaudhary R, Chilappagari P, Cieslik M, Colaprico A, Zhou DC, Day C, Domagalski MJ, Selvan ME, Fenyö D, Foltz SM, Francis A, Gonzalez-Robles T, Gümüş ZH, Heiman D, Holck M, Hong R, Hu Y, Jaehnig EJ, Ji J, Jiang W, Katsnelson L, Ketchum KA, Klein RJ, Lei JT, Liang W, Liao Y, Lindgren CM, Ma W, Ma L, MacCoss MJ, Rodrigues FM, McKerrow W, Nguyen N, Oldroyd R, Pilozzi A, Pugliese P, Reva B, Rudnick P, Ruggles KV, Rykunov D, Savage SR, Schnaubelt M, Schraink T, Shi Z, Singhal D, Song X, Storrs E, Terekhanova NV, Thangudu RR, Thiagarajan M, Wang L, Wang JM, Wang Y, Wen B, Wu Y, Wyczalkowski MA, Xin Y, Yao L, Yi X, Zhang H, Zhang Q, Zuhl M, Getz G, Ding L, Nesvizhskii AI, Wang P, Robles AI, Zhang B, Payne SH, Lazar AJ, Paulovich AG, Colaprico A, Iavarone A, Chinnaiyan AM, Druker BJ, Kumar-Sinha C, Newton CJ, Huang C, Mani DR, Smith RD, Huntsman E, Schadt EE, An E, Petralia F, Hostetter G, Omenn GS, Cho H, Rodriguez H, Zhang H, Kolodziejczak I, Johnson JL, Bavarva J, Tan J, Rodland KD, Clauser KR, Krug K, Cantley LC, Wiznerowicz M, Ellis MJ, Anurag M, Mesri M, Gillette MA, Birrer MJ, Ceccarelli M, Dhanasekaran SM, Edwards N, Tignor N, Babur Ö, Pugliese P, Gosline SJ, Jewell SD, Satpathy S, Chowdhury S, Schürer S, Carr SA, Liu T, Hiltke T, Yaron TM, Stathias V, Liu W, Zhang X, Song Y, Zhang Z, Chan DW, Clinical Proteomic Tumor Analysis Consortium. Proteogenomic data and resources for pan-cancer analysis. Cancer cell 41(8):1397-1406, 2023. e-Pub 2023. PMID: 37582339.
      2. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161(6):1961-71, 2002. e-Pub 2002. PMID: 12466110.

      Other Articles

      1. Skerget, S, Penaherrera, D, Chari, A, Jagannath, S, Siegel, D, Vij, R, Orloff, GJ, Jakubowiak, AJ, Niesvizky, R, Liles, DK, Berdeja, JG, Levy, MY, Wolf, J, Usmani, S, Steis, RG, Srinivas, S, Roy, V, Rodríguez, P, Oriol, A, Kumar, SK, Krsnik, I, Matkiwsky, M, Girnius, SK, Conde, M, Chandra, S, Anderson, R, Solomon, W, Richards, DA, Patel, D, Menter, AR, Kaya, H, Hsu, G, Hassoun, H, Bargay, J, Anderson, L, Abella, E, Yalamachili, M, Wachsman, W, Volterra, F, Onitilo, AA, Min, F, Shieh, M, Bar, MH, Ngaiza, J, Harris, W, Sebag, M, Robles, R, Yost, KJ, Grossbard, M, Jewell, SD Correction to. Nature Genetics 57(7):1789, 2025. PMID: 40490515.
      2. Wu, Y, Terekhanova, NV, Caravan, W, Naser Al Deen, N, Lal, P, Chen, S, Mo, CK, Cao, S, Li, Y, Karpova, A, Liu, R, Zhao, Y, Shinkle, A, Strunilin, I, Weimholt, C, Sato, K, Yao, L, Serasanambati, M, Yang, X, Wyczalkowski, MA, Zhu, H, Zhou, DC, Jayasinghe, RG, Mendez, D, Wendl, MC, Clark, DJ, Newton, CJ, Ruan, Y, Reimers, MA, Pachynski, RK, Kinsinger, C, Jewell, SD, Chan, DW, Zhang, H, Chaudhuri, AA, Chheda, MG, Humphreys, BD, Mesri, M, Rodriguez, H, Hsieh, JJ, Ding, L, Chen, F Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. Nat Commun 14(1), 2023. PMID: 37198186.
      3. Bagchi, A, Beddows, I, Cornelius, AS, Robinson, G, Jewell, SD Rare cases of medulloblastoma with hypermutation. Cancer Rep (Hoboken) 5(5), 2022. PMID: 34351088.
      4. Paulauskis JD, Blanc VM, Carey T, Chesla DW, Frey RC, Geddes T, Keats J, Loup A, Pruetz B, Rohrer DC, Valley DR, Tomlinson T, Akervall J, Wilson GD, Jewell SD Great Lakes Biorepository Research Network's Annual Biobanking Symposium: A Focus on Precision Medicine. Biopreserv Biobank 17(6):598-602, 2019. PMID: 31211591.
      5. Stranger BE, Brigham LE, Hasz R, Hunter M, Johns C, Johnson M, Kopen G, Leinweber WF, Lonsdale JT, McDonald A, Mestichelli B, Myer K, Roe B, Salvatore M, Shad S, Thomas JA, Walters G, Washington M, Wheeler J, Bridge J, Foster BA, Gillard BM, Karasik E, Kumar R, Miklos M, Moser MT, Jewell SD, Montroy RG, Rohrer DC, Valley DR, Davis DA, Mash DC, Gould SE, Guan P, Koester S, Little A, Martin C, Moore HM, Rao A, Struewing JP, Volpi S, Hansen KD, Hickey PF, Rizzardi LF, Hou L, Liu Y, Molinie B, Park Y, Rinaldi N, Wang L, Wittenberghe NV, Claussnitzer M, Gelfand ET, Li Q, Linder S, Zhang R, Smith KS, Tsang EK, Chen LS, Demanelis K, Doherty JA, Jasmine F, Kibriya MG, Jiang L, Lin S, Wang M, Jian R, Li X, Chan J, Bates D, Diegel M, Halow J, Haugen E, Johnson A, Kaul R, Lee K, Maurano MT, Nelson J, Neri FJ, Sandstrom R, Fernando MS, Linke C, Oliva M, Skol A, Wu F, Akey JM, Feinberg AP, Li JB, Pierce BL, Stamatoyannopoulos JA, Tang H, Ardlie KG, Kellis M, Snyder MP, Montgomery SB Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease. Nat Genet 49(12):1664-1670, 2017. PMID: 29019975.
      6. Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, Foster B, Moser M, Karasik E, Gillard B, Ramsey K, Sullivan S, Bridge J, Magazine H, Syron J, Fleming J, Siminoff L, Traino H, Mosavel M, Barker L, Jewell S, Rohrer D, Maxim D, Filkins D, Harbach P, Cortadillo E, Berghuis B, Turner L, Hudson E, Feenstra K, Sobin L, Robb J, Branton P, Korzeniewski G, Shive C, Tabor D, Qi L, Groch K, Nampally S, Buia S, Zimmerman A, Smith A, Burges R, Robinson K, Valentino K, Bradbury D, Cosentino M, Diaz-Mayoral N, Kennedy M, Engel T, Williams P, Erickson K, Ardlie K, Winckler W, Getz G, DeLuca D, MacArthur D, Kellis M, Thomson A, Young T, Gelfand E, Donovan M, Meng Y, Grant G, Mash D, Marcus Y, Basile M, Liu J, Zhu J, Tu Z, Cox NJ, Nicolae DL, Gamazon ER, Im HK, Konkashbaev A, Pritchard J, Stevens M, Flutre T, Wen X, Dermitzakis ET, Lappalainen T, Guigo R, Monlong J, Sammeth M, Koller D, Battle A, Mostafavi S, McCarthy M, Rivas M, Maller J, Rusyn I, Nobel A, Wright F, Shabalin A, Feolo M, Sharopova N, Sturcke A, Paschal J, Anderson JM, Wilder EL, Derr LK, Green ED, Struewing JP, Temple G, Volpi S, Boyer JT, Thomson EJ, Guyer MS, Ng C, Abdallah A, Colantuoni D, Insel TR, Koester SE, Little A, Bender PK, Lehner T, Yao Y, Compton CC, Vaught JB, Sawyer S, Lockhart NC, Demchok J, Moore HF The Genotype-Tissue Expression (GTEx) project. Nat Genet 45(6):580-5, 2013. PMID: 23715323.

      Abstracts

      1. Kresty LA, Stoner GD, Normolle D, Beer DG, Appelman H, Eaton T, Fromkes J, Sundaram U, Moselely R, Spechler S, Habib S, Nostrant T, Jewell SD. Chemoprevention in Esophageal Cancer. Proceedings AACR 41:223-224, 2000. e-Pub 2000.
      2. Bhatt UY, McKeegan C, Urban K, Dakappagari N, Johnson A, Williams C, Sas J, Ellison J, Kaumaya PT, Jewell SD, Sferra TJ, Nahman Jr NS. Distribution of the coxasakie-adenovirus receptor protein in the human kidney. American Society of Gene Therapy, 2000. e-Pub 2000.
      3. Jewell S, Hazard K. Mesenterico-caval shunt abrogates the induction of oral tolerance to myelin basic protein: Liver associated mechanisms in oral tolerance. FASEB J 13(4):Part 1, 1999. e-Pub 1999.
      4. Jewell SD, Dierksheide J, Curry A, Shrestha AK. Suppression of experimental autoimmune encephalomyelitis (EAE) by portal vein (PV) injection of myelin basic protein (MBP). FASEB J 12:A600, 1998. e-Pub 1998.
      5. Martin EW, Jewell SD, Hitchcock CL. Radioimmunoguided detection of colon cancer. Third International Oncology Conference, 1996. e-Pub 1996.
      6. Jewell SD, Hazard KR, Shrestha AK. Effects on lymphocyte proliferation by human mucin isolated from colon cancer and normal colonic mucosa. Annual Conference on Clinical Immunology, 1996. e-Pub 1996.
      7. Jewell SD, Edwards D, Houchens D, Eisenhardt W, Martin Jr E, Hitchcock C. Injection of a murine monoclonal antibody to the TAG-72 antigen leads to changes in lymphocyte subpopulations in the peripheral blood. FASEB J 9(4):A1045, 1995. e-Pub 1995.
      8. Cordial C, Jewell SD, Hitchcock C, and Pellegrini A. Can nuclear DNA and proliferation markers be evaluated by image cytometry to objectively distinguish between malignant melanoma and spitz nevi?. J Cutan Pathol, 1995. e-Pub 1995.
      9. Jewell SD, Cox K, Gienapp I, Whitacre C. Oral tolerance in Experimental autoimmune encephalomyelitis (EAE): Lack of demonstrable bystander suppression in lymphoid tissue 8:245A, 1994. e-Pub 1994.
      10. Javed N, Jewell SD, Gienapp I, Cox K, Whitacre C. Oral tolerance in experimental autoimmune encephalomyelitis: Role of gastrointestinal lymphoid cells. FASEB J 8:245A, 1994. e-Pub 1994.
      11. Fox CC, Jewell SD. Antigen presentation by highly enriched mast cell populations. J Immunol 150:145A, 1993. e-Pub 1993.
      12. Whitacre C, Gienapp I, Cox K, Jewell SD, Javed N, Goldman S, Heber-Katz H. Oral tolerance in experimental autoimmune encephalomyelitis (EAE): T cell anergy. J Immunol 150:245A, 1993. e-Pub 1993.
      13. Fox CC, Jewell SD. Rat peritoneal mast cells express MHC class II antigens. J Allergy Clin Immunol 91(1 (Part 2)):159, 1993. e-Pub 1993.
      14. Whitacre CC, Apseloff G, Cox K, Matkovic V, Jewell SD, Gerber N. Suppression of experimental autoimmune encephalomyelitis (EAE) by gallium nitrate. FASEB J 6:4336, 1992. e-Pub 1992.
      15. O'Dorisio SM, O'Dorisio TM, Jewell SD, Sirinek L, Qualman S, Harmel R. Intestinal transplantation: Model of neuropeptide modulation of mucosal immunity. FASEB J 5:7680, 1991. e-Pub 1991.
      16. Allenby PA, Tuttle SE, O'Toole RV, Jewell SD. Demonstration of human papilloma virus in cervical lesions: In situ hybridization compared with immunohistochemistry. Am J Clin Pathol 91:358, 1989. e-Pub 1989.
      17. Walker AH, Tuttle SE, Jewell SD, Bucci DM, Goodwin RA. A,B,H antigen expression in primary and autologous metastatic colon carcinomas: Evaluation of heterogenicity using monoclonal antibodies. Am J Clin Pathol 87:417, 1987. e-Pub 1987.
      18. Zibas J, Tuttle SE, Bucci D, Oredipe L, Jewell SD, Greiner J, Primus J, Steplewski Z, Schlom J. Flow cytometric phenotyping of colon carcinoma cells using a panel of monoclonal antibodies: Alteration of membrane phenotype by alpha interferon. Int Acad Pathol Congress, 1987. e-Pub 1987.
      19. Goodwin RA, Tuttle SE, Jewell SD, Bucci DM, Martin EW, Steplewski Z. Heterogeneity of gastrointestinal carcinoma associated antigen (19-9 AG) in primary and metastatic gastrointestinal tumors. Am J Clin Pathol 87:416, 1987. e-Pub 1987.
      20. Barth RF, Oredipe OA, Tuttle SE, Adams DM, Bucci DM, Mojzisik CM, Hinkle GH, Jewell SD, Thurston MO, Martin EW, Steplewski Z. Relationship between tumor burden, antibody affinity, and radioimmunodetection of colon cancer. Covalently Modified Antigens and Antibodies in Diagnosis and Therapy, 1987. e-Pub 1987.
      21. Porter D, Tuttle SE, Bucci DM, Jewell SD, Colcher D, Schlom J. Distribution of B72.3 antigen in primary and metastatic colorectal carcinoma. International Academy of Pathology Congress 1987, 1987. e-Pub 1987.
      22. Hinkle G, Tuttle SE, Oreidpe O, Miller E, Jewell SD, Adams D, Rousseau M, Barth R, Houchens D, Steplewski Z, Thurston M, Martin E. Preferential localization of monoclonal antibody in human colon cancer xenografts: Relation to cell surface antigen density. American Association for Cancer Research (AACR), 1986. e-Pub 1986.
      23. Oredipe OA, Barth RF, Tuttle SE, Houchens DP, Thurston MO, Hinkle GH, Mojzisik CM, Adams D, Sautins I, O'Dwyer P, Miller EA, Jewell SD, Bucci D, Ridihalgh J, Steplewski Z, Martin EW. The use of monoclonal antibodies directed against human colorectal cancer for radioimmunodetection by a handheld gamma probe. American Association for Cancer Research (AACR), 1986. e-Pub 1986.
      24. Martin EW, Tuttle SE, Rousseau M, Mojzisik CM, O'Dwyer PJ, Hinkle GH, Miller EA, Goodwin RA, Oredipe OA, Barth RF, Olson JO, Houchens D, Jewell SD, Bucci DM, Adams D, Steplewski Z, Thurston MO. Radioimmunoguided surgery with monoclonal antibodies in colorectal cancer. Wistar Symposium; Immunodiagnosis and immunotherapy with CO17-1A monoclonal antibody in gastrointestinal cancer, 1986. e-Pub 1986.
      25. Tuttle SE, Barth RF, Hinkle GH, Thurston MO, Oredipe O, Bucci DM, Mojzisik CM, O'Dwyer PJ, Miller E, Adams D, Jewell SD, Houchens D, Steplewski Z, Martin EW. Intra-operative gamma probe localization of radiolabeled monoclonal antibody directed against human colon carcinoma. International Conference on Monoclonal Antibody Immunoconjugates for Cancer, 1986. e-Pub 1986.
      26. Jewell SD, Rohrer DC, Blanc V, Carey TE, Tomlinson T, Pruetz B, Akervall J, Wilson G. Great Lakes Biorepository Research Network (GLBRN) in Action. International Society for Biological and Environmental Repositories (ISBER) 2017 Annual Meeting: Due North: Aligning Biobanking Practice with Evolving Evidence and Innovation.
      27. Johnson AB, Wick MP, Bhatt UY, Williams C, Sas J, Shie S, Jewell SD, Sferra TJ, Nahman Jr NS. Adenoviral- microsphere complexes for glomerular gene delivery: Potential ischemic and inflammatory events following microparticle embolization. Ohio State University, Depts. Of Medicine, Animal Sciences, Pediatrics, and Pathology.
      28. Jewell SD, Williams N, McCart LM, Ward BS, Sedmak DD. Analysis of the molecular quality of tissue specimens from the Cooperative Human Tissue Network (CHTN). International Society for Biological and Environmental Repositories (ISBER) 2001 Annual Meeting.
      29. Srinivasan M, Long S, Yearsley K, Hout B, Jewell SD. Importance of fixation and storage in the molecular quality of tissue. Exp Biology 2003.
      30. Hitchcock C, Jewell SD. Use of virtual slide technology in diagnosis and teaching. 3rd Croatian Congress of Pathology.
      31. Edelman MJ, Watson DM, Wang X, Kratzke RA, Mauer AM, Jewell SD, Graziano SL, Masters GA, Bedor MM, Green MR. EE Vokes for the CALGB Randomized phase II trial of eicosanoid modulator pathways in advanced non-small cell lung cancer. American Association of Clinical Oncology.
      32. Hostetter G, Syring M, Watanabe A, Buchholz S, Trent J, Jewell SD, Duggan D, Carpten J. Tumor heterogeneity and high content assays: importance of tissue chain of custody. 4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science.
      33. Barney T, Resau J, Jewell SD, Campbell B, Christ N, Hawkins H. Neonatal Blood Spot Card Biorepository Sample Processing. International Society for Biological and Environmental Repositories (ISBER) 2011 Annual Meeting.
      34. Jewell SD, Rohrer D, Maxim D, Berghuis B, Turner L, Harbach P, Feenstra K, Hudson E, Selinsky C, Trent J, Buia S, Zimmerman A, Burges R, Shive C, Smith A, Tabor D, Korzeniewski G, Sobin L, Madden J, Lockhart N, Sawyer S, Branton P, Vaught J, Compton C. Comprehensive Biospecimen Resource for the caHUB. International Society for Biological and Environmental Repositories (ISBER) 2012 Annual Meeting.
      35. Jewell SD, Rohrer D, Khoo SK, Hilsabeck R, Maxim D, Kidd P, Collison K, Selinsky C, Carpten J, Keats J, Trent J, Perkins L, Hoban C. Biospecimen Resource for the Multiple Myeloma Research Foundation CoMMpass SM Study. International Society for Biological and Environmental Repositories (ISBER) 2012 Annual Meeting.
      36. Hostetter G, Varlan P, Berghuis B, Turner L, Beck J, Khoo SK, Monsma D, Jewell SD. Assessment of RNA Quality in PAXgene-Fixed Paraffin-Embedded (PFPE) Tissue. GTEx Annual Meeting.
      37. Collins E, Beck J, Monsma D, Dylewski D, Borgman A, Winn M, Turner L, Judson C, Hostetter G, Jewell SD. Illuminating the effects of tissue degradation: Improving the management of tissues used in cancer research or clinical applications. American Association for Cancer Research (AACR).
      38. Valley D, DeHollander M, McPeak E, Harbach P, Rohrer D, Jewell SD. The Impact of a Comprehensive Quality Management Program, RS-21. International Society for Biological and Environmental Repositories (ISBER) 2014 Annual Meeting.
      39. Rohrer D, Valley D, Berghuis B, Maxim D, Buia S, Smith A, Valentino K, Zimmerman A, Korzeniewski G, Burges R, Carithers L, Guan P, Rao A, Vaught J, Sawyer S, Moore H, Jewell SD. Biorepository Management as the Comprehensive Biospecimen Resource (CBR) for the National Cancer Institute’s (NCI) cancer Human Biobank (caHUB). International Society for Biological and Environmental Repositories (ISBER) 2014 Annual Meeting.
      40. Jewell SD, Rohrer D, Blanski A, Hodges M, Hudson E, Harbach P, Berghuis B, Hilsabeck R, Kidd P, Collision K, Keats J, Auclair D, Carpten J. The Van Andel Research Institute’s Program for Biospecimen Science Biorepository Management for the Multiple Myeloma Research Foundation’s CoMMpass Clinical Trial, HSR-6. International Society for Biological and Environmental Repositories (ISBER) 2014 Annual Meeting.
      41. Hostetter G, Barney T, Resau J, Collins E, Turner L, Berghuis B, Wang X, Joynt C, Sinha A, Feinstein T, Cherba D, Winn M, Sempere L, Haab B, Jewell S. A Tissue Microarray Study to Characterize Macrophages in Colorectal Cancer. Van Andel Research Institute Scientific Retreat.
      42. Lonial S, Yellapantula V, Liang W, Kurdoglu A, Russell M, Christofferson A, Aldrich J, Legendre C, Stephenson K, Cuyugan L, Adkins J, McDonald J, Helland A, Blanski A, Rohrer D, Derome M, Auclair D, Kidd P, Jewell SD, Craig D, Carpten J, Keats J. Interim Analysis of the MMRF CoMMpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression. 56th Meeting of the American Society of Hematology (ASH).
      43. Carithers L, Agarwal R, Barcus M, Branton P, Burges R, Guan P, Hostetter G, Jewell SD, Odeh H, Roche N, Sachs M, Smith A, Sobin L, Soria C, Valentino K, Winn M, Moore H. Emerging Results from the NCI Biospecimen Pre-analytical Variables (BPV) Program. National Cancer Research Institute, Leidos Biomedical Research, Van Andel Research Institute.
      44. Collins E, Hostetter G, Jeltema D, Eugster E, Borgman A, Winn M, Monsma D, Zhang B, Liu M, Ramjan Z, Jewell SD, Pfeifer G. Comprehensive and Targeted Genomics: VARI Core Services. Van Andel Research Institute Scientific Retreat.
      45. Guan P, Agarwal R, Odeh H, Carithers L, Jones W, Brown C, Jasper J, Barcus M, Bavarva J, Burges R, Branton P, Camalier C, Das B, Lih J, Roche N, Sachs D, Sobin L, Jewell S, Smith A, Soria C, Valentino K, Valley D, Williams M, Moore H. Pre-analytical Impacts on RNA and DNA Quality and Next Generation Sequencing from Formalin-Fixed Paraffin Embedded (FFPE) Tumor Tissue. National Cancer Institute, BPV Face-to-Face Meeting.
      46. Manojlovic Z, Christofferson A, Legendre C, Speyer G, Kim S, Liang W, Mulligan G, Kidd P, Jewell SD, Derome M, Troups J, Auclair D, Lonial S, Craig D, Keats J, Carpten J. In-Depth Molecular Profiling of Multiple Myeloma in African Americans. 57th American Society of Hematology (ASH) Annual Meeting & Exposition.
      47. Guan P, Agarwal R, Odeh H, Carithers L, Jones W, Brown C, Jasper J, Barcus M, Bavara J, Burges R, Branton P, Camalier C, Das B, Lih J, Roche N, Rohrer D, Sachs M, Sobin L, Jewell S, Smith A, Soria C, Valentino K, Valley D, Williams M, Moore H. Pre-analytical Impacts on RNA and DNA Quality and Next Generation Sequencing from Formalin-Fixed Paraffin Embedded (FFPE) Tumor Tissue. International Society for Biological and Environmental Repositories (ISBER) 2016 Annual Meeting: Breaking Down Walls: Unifying Biobanking Communities to Secure Our Sustainability.
      48. Shea K, Ramirez N, Branton P, Abbott S, Blanc V, Dash R, Dry S, Gastier-Foster J, Jewell S, McCall S, Rose J, Yeransian N. The CAP Biorepository Accreditation Program: Results from the First Four Years of the Program. International Society for Biological and Environmental Repositories (ISBER) 2016 Annual Meeting: Breaking Down Walls: Unifying Biobanking Communities to Secure Our Sustainability.
      49. Agarwal R, Carithers L, Odeh H, Branton P, Barcus M, Roche N, Burges R, Smith A, Valentino K, Soria C, Bavarva J, Sobin L, Lih J, Williams M, Camalier C, Das B, Sachs M, Rohrer D, Jewell S, Valley D. Impact of Biospecimen Pre-Analytical Factors on Molecular Analysis. American Association for Cancer Research (AACR) Annual Meeting.
      50. Valley DR, Rohrer DC, Jewell SD, Guan P, Moore HM. Biospecimen Pre-analytical Variables (BPV) Program Sample Collection Availability. International Society for Biological and Environmental Repositories (ISBER) 2017 Annual Meeting: Due North: Aligning Biobanking Practice with Evolving Evidence and Innovation.
      51. Ammerlaan W, Mathay C, Mommaerts K, Trouet J, Kovanova OA, Bellora C, Frasquilho S, Iambert P, Rohrer D, Valley DR, Blanski A, Jewell SD, Sachs M, Guan P, Mathieson W, Moore H, Betsou F. RNA and miRNA Expression Profiles in FFPE Tissues Subjected to Extended Ischemic and Formalin-Fixation Times. International Society for Biological and Environmental Repositories (ISBER) 2017 Annual Meeting: Due North: Aligning Biobanking Practice with Evolving Evidence and Innovation.

      Book Chapters

      1. Jewell, S, Madeleine, A, Williams, MA. Regulatory Considerations for Research Biorepositories. In: Cellular Therapy: Principles, Methods, and Regulations. 2nd. American Association of Blood Banks (AABB), 510-519, 2016.
      2. Pan T, Jewell S, Catalyurek U, Wenzel P, Leone G, Hastings S, Oster S, Langella S, Kurc T, Saltz J, Cowden D. Virtual microscopy: Distributed image storage, retrieval, analysis, and visualization. In: Parallel Computing for Bioinformatics and Computational Biology. John Wiley and Sons, Inc, 737-763, 2005.

      Books (edited and written)

      1. Hansel DE, Jewell SD. Developing and Organizing an Institutional Biospecimen Repository. College of American Pathologist (CAP) Press, 2016.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 17, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top